500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Ebenau JL, van der Lee SJ, Hulsman M, Tesi N, Jansen IE, Verberk IMW, van Leeuwenstijn M, Teunissen CE, Barkhof F, Prins ND, Scheltens P, Holstege H, van Berckel BNM, van der Flier WM. Risk of dementia in ε4 carriers is mitigated by a polygenic risk score. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12229. PMID 34541285 DOI: 10.1002/dad2.12229  1
2021 Bridel C, Leurs CE, van Lierop ZY, van Kempen ZL, Dekker I, Twaalfhoven HA, Moraal B, Barkhof F, Uitdehaag BM, Killestein J, Teunissen CE. Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis. Neurology. PMID 34504023 DOI: 10.1212/WNL.0000000000012752  1
2021 Pemberton HG, Zaki LAM, Goodkin O, Das RK, Steketee RME, Barkhof F, Vernooij MW. Technical and clinical validation of commercial automated volumetric MRI tools for dementia diagnosis-a systematic review. Neuroradiology. PMID 34476511 DOI: 10.1007/s00234-021-02746-3  1
2021 Lukas C, Bellenberg B, Prados F, Valsasina P, Parmar K, Brouwer I, Pareto D, Rovira À, Sastre-Garriga J, Gandini Wheeler-Kingshott CAM, Kappos L, Rocca MA, Filippi M, Yiannakas M, Barkhof F, et al. Quantification of Cervical Cord Cross-Sectional Area: Which Acquisition, Vertebra Level, and Analysis Software? A Multicenter Repeatability Study on a Traveling Healthy Volunteer. Frontiers in Neurology. 12: 693333. PMID 34421797 DOI: 10.3389/fneur.2021.693333  1
2021 Pelkmans W, Ossenkoppele R, Dicks E, Strandberg O, Barkhof F, Tijms BM, Pereira JB, Hansson O. Tau-related grey matter network breakdown across the Alzheimer's disease continuum. Alzheimer's Research & Therapy. 13: 138. PMID 34389066 DOI: 10.1186/s13195-021-00876-7  1
2021 van Duinkerken E, IJzerman RG, Barkhof F, Moll AC, Diamant M, Snoek FJ, Klein M. Cognitive Functioning and Hippocampal Connectivity in Patients With Longstanding Type 1 Diabetes and Apolipoprotein E ε4. Diabetes Care. PMID 34380705 DOI: 10.2337/dc21-0483  1
2021 Zheng F, Li Y, Zhuo Z, Duan Y, Cao G, Tian D, Zhang X, Li K, Zhou F, Huang M, Li H, Li Y, Zeng C, Zhang N, Sun J, ... ... Barkhof F, et al. Structural and functional hippocampal alterations in Multiple sclerosis and neuromyelitis optica spectrum disorder. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211032800. PMID 34379008 DOI: 10.1177/13524585211032800  1
2021 Collij LE, Mastenbroek SE, Salvadó G, Wink AM, Visser PJ, Barkhof F, van Berckel BNM, Lopes Alves I. Regional amyloid accumulation predicts memory decline in initially cognitively unimpaired individuals. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12216. PMID 34368416 DOI: 10.1002/dad2.12216  1
2021 Shi L, Buckley NJ, Bos I, Engelborghs S, Sleegers K, Frisoni GB, Wallin A, Lléo A, Popp J, Martinez-Lage P, Legido-Quigley C, Barkhof F, Zetterberg H, Visser PJ, Bertram L, et al. Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies. Frontiers in Aging Neuroscience. 13: 712545. PMID 34366831 DOI: 10.3389/fnagi.2021.712545  1
2021 Ulugut H, Dijkstra AA, Scarioni M, Barkhof F, Scheltens P, Rozemuller AJM, Pijnenburg YAL. Right temporal variant frontotemporal dementia is pathologically heterogeneous: a case-series and a systematic review. Acta Neuropathologica Communications. 9: 131. PMID 34344452 DOI: 10.1186/s40478-021-01229-z  1
2021 Bocancea DI, Catharina van Loenhoud A, Groot C, Barkhof F, van der Flier WM, Ossenkoppele R. Measuring Resilience and Resistance in Aging and Alzheimer Disease Using Residual Methods: A Systematic Review and Meta-analysis. Neurology. PMID 34266918 DOI: 10.1212/WNL.0000000000012499  1
2021 Müller DMJ, Robe PA, Ardon H, Barkhof F, Bello L, Berger MS, Bouwknegt W, Van den Brink WA, Conti Nibali M, Eijgelaar RS, Furtner J, Han SJ, Hervey-Jumper SL, Idema AJS, Kiesel B, et al. On the cutting edge of glioblastoma surgery: where neurosurgeons agree and disagree on surgical decisions. Journal of Neurosurgery. 1-11. PMID 34243150 DOI: 10.3171/2020.11.JNS202897  1
2021 Hartung HP, Derfuss T, Cree BA, Sormani MP, Selmaj K, Stutters J, Prados F, MacManus D, Schneble HM, Lambert E, Porchet H, Glanzman R, Warne D, Curtin F, Kornmann G, ... ... Barkhof F, et al. Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211024997. PMID 34240656 DOI: 10.1177/13524585211024997  1
2021 Ulugut H, Stek S, Wagemans LEE, Jutten RJ, Keulen MA, Bouwman FH, Prins ND, Lemstra AW, Krudop W, Teunissen CE, van Berckel BNM, Ossenkoppele R, Barkhof F, van der Flier WM, Scheltens P, et al. The natural history of primary progressive aphasia: beyond aphasia. Journal of Neurology. PMID 34216263 DOI: 10.1007/s00415-021-10689-1  1
2021 Wolters EE, Papma JM, Verfaillie SCJ, Visser D, Weltings E, Groot C, van der Ende EL, Giannini LAA, Tuncel H, Timmers T, Boellaard R, Yaqub M, van Assema DME, Kuijper DA, Segbers M, ... ... Barkhof F, et al. [18F]Flortaucipir PET Across Various Mutations in Presymptomatic and Symptomatic Carriers. Neurology. PMID 34210823 DOI: 10.1212/WNL.0000000000012448  1
2021 Kommers I, Bouget D, Pedersen A, Eijgelaar RS, Ardon H, Barkhof F, Bello L, Berger MS, Conti Nibali M, Furtner J, Fyllingen EH, Hervey-Jumper S, Idema AJS, Kiesel B, Kloet A, et al. Glioblastoma Surgery Imaging-Reporting and Data System: Standardized Reporting of Tumor Volume, Location, and Resectability Based on Automated Segmentations. Cancers. 13. PMID 34201021 DOI: 10.3390/cancers13122854  1
2021 Stellingwerff MD, Al-Saady ML, van de Brug T, Barkhof F, Pouwels PJW, van der Knaap MS. MRI Natural History of the Leukodystrophy Vanishing White Matter. Radiology. 210110. PMID 34184934 DOI: 10.1148/radiol.2021210110  1
2021 Groot C, Risacher SL, Chen JQA, Dicks E, Saykin AJ, Mac Donald CL, Mez J, Trittschuh EH, Mukherjee S, Barkhof F, Scheltens P, van der Flier WM, Ossenkoppele R, Crane PK. Differential trajectories of hypometabolism across cognitively-defined Alzheimer's disease subgroups. Neuroimage. Clinical. 31: 102725. PMID 34153688 DOI: 10.1016/j.nicl.2021.102725  1
2021 Wattjes MP, Ciccarelli O, Reich DS, Banwell B, de Stefano N, Enzinger C, Fazekas F, Filippi M, Frederiksen J, Gasperini C, Hacohen Y, Kappos L, Li DKB, Mankad K, Montalban X, ... ... Barkhof F, et al. 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. The Lancet. Neurology. PMID 34139157 DOI: 10.1016/S1474-4422(21)00095-8  1
2021 Zhuo Z, Qu L, Zhang P, Duan Y, Cheng D, Xu X, Sun T, Ding J, Xie C, Liu X, Haller S, Barkhof F, Zhang L, Liu Y. Prediction of H3K27M-mutant brainstem glioma by amide proton transfer-weighted imaging and its derived radiomics. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34131804 DOI: 10.1007/s00259-021-05455-4  1
2021 Ferreira D, Nedelska Z, Graff-Radford J, Przybelski SA, Lesnick TG, Schwarz CG, Botha H, Senjem ML, Fields JA, Knopman DS, Savica R, Ferman TJ, Graff-Radford NR, Lowe VJ, Jack CR, ... ... Barkhof F, et al. Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodies. Neurobiology of Aging. 105: 252-261. PMID 34130107 DOI: 10.1016/j.neurobiolaging.2021.04.029  1
2021 Huiskamp M, Eijlers AJC, Broeders TAA, Pasteuning J, Dekker I, Uitdehaag BMJ, Barkhof F, Wink AM, Geurts JJG, Hulst HE, Schoonheim MM. Longitudinal Network Changes and Conversion to Cognitive Impairment in Multiple Sclerosis. Neurology. PMID 34099528 DOI: 10.1212/WNL.0000000000012341  1
2021 Müller DMJ, De Swart ME, Ardon H, Barkhof F, Bello L, Berger MS, Bouwknegt W, Van den Brink WA, Conti Nibali M, Eijgelaar RS, Furtner J, Han SJ, Hervey-Jumper S, Idema AJS, Kiesel B, et al. Timing of glioblastoma surgery and patient outcomes: a multicenter cohort study. Neuro-Oncology Advances. 3: vdab053. PMID 34056605 DOI: 10.1093/noajnl/vdab053  1
2021 Verburg N, Barthel FP, Anderson KJ, Johnson KC, Koopman T, Yaqub MM, Hoekstra OS, Lammertsma AA, Barkhof F, Pouwels PJW, Reijneveld JC, Rozemuller AJM, Beliën JAM, Boellaard R, Taylor MD, et al. Spatial concordance of DNA methylation classification in diffuse glioma. Neuro-Oncology. PMID 34049406 DOI: 10.1093/neuonc/noab134  1
2021 Eshaghi A, Young AL, Wijeratne PA, Prados F, Arnold DL, Narayanan S, Guttmann CRG, Barkhof F, Alexander DC, Thompson AJ, Chard D, Ciccarelli O. Author Correction: Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data. Nature Communications. 12: 3169. PMID 34016975 DOI: 10.1038/s41467-021-23538-6  1
2021 Hong S, Dobricic V, Ohlei O, Bos I, Vos SJB, Prokopenko D, Tijms BM, Andreasson U, Blennow K, Vandenberghe R, Gabel S, Scheltens P, Teunissen CE, Engelborghs S, Frisoni G, ... ... Barkhof F, et al. TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33991015 DOI: 10.1002/alz.12330  1
2021 Granziera C, Wuerfel J, Barkhof F, Calabrese M, De Stefano N, Enzinger C, Evangelou N, Filippi M, Geurts JJG, Reich DS, Rocca MA, Ropele S, Rovira À, Sati P, Toosy AT, et al. Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis. Brain : a Journal of Neurology. PMID 33970206 DOI: 10.1093/brain/awab029  1
2021 Collorone S, Prados F, Kanber B, Cawley NM, Tur C, Grussu F, Solanky BS, Yiannakas M, Davagnanam I, Wheeler-Kingshott CAMG, Barkhof F, Ciccarelli O, Toosy AT. Brain microstructural and metabolic alterations detected in vivo at onset of the first demyelinating event. Brain : a Journal of Neurology. PMID 33903905 DOI: 10.1093/brain/awab043  1
2021 Groot C, Grothe MJ, Mukherjee S, Jelistratova I, Jansen I, van Loenhoud AC, Risacher SL, Saykin AJ, Mac Donald CL, Mez J, Trittschuh EH, Gryglewski G, Lanzenberger R, Pijnenburg YAL, Barkhof F, et al. Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer's disease subgroups. Neuroimage. Clinical. 30: 102660. PMID 33895633 DOI: 10.1016/j.nicl.2021.102660  1
2021 van Lierop ZY, Wieske L, Koel-Simmelink MJ, Chatterjee M, Dekker I, Leurs CE, Willemse EA, Moraal B, Barkhof F, Eftimov F, Uitdehaag BM, Killestein J, Teunissen CE. Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211010097. PMID 33890520 DOI: 10.1177/13524585211010097  1
2021 de Sitter A, Burggraaff J, Bartel F, Palotai M, Liu Y, Simoes J, Ruggieri S, Schregel K, Ropele S, Rocca MA, Gasperini C, Gallo A, Schoonheim MM, Amann M, Yiannakas M, ... ... Barkhof F, et al. Development and evaluation of a manual segmentation protocol for deep grey matter in multiple sclerosis: Towards accelerated semi-automated references. Neuroimage. Clinical. 30: 102659. PMID 33882422 DOI: 10.1016/j.nicl.2021.102659  1
2021 van Engelen ME, Rozemuller AJM, Ulugut Erkoyun H, Groot C, Fieldhouse JLP, Koene T, Ossenkoppele R, Gossink FT, Krudop WA, Vijverberg EGB, Dols A, Barkhof F, Berckel BNMV, Scheltens P, Brain Bank N, et al. The bvFTD phenocopy syndrome: a case study supported by repeated MRI, [F]FDG-PET and pathological assessment. Neurocase. 1-9. PMID 33881963 DOI: 10.1080/13554794.2021.1905855  1
2021 Haider L, Prados F, Chung K, Goodkin O, Kanber B, Sudre C, Yiannakas M, Samson RS, Mangesius S, Thompson AJ, Gandini Wheeler-Kingshott CAM, Ciccarelli O, Chard DT, Barkhof F. Cortical involvement determines impairment 30 years after a clinically isolated syndrome. Brain : a Journal of Neurology. PMID 33880511 DOI: 10.1093/brain/awab033  1
2021 Colato E, Stutters J, Tur C, Narayanan S, Arnold DL, Gandini Wheeler-Kingshott CAM, Barkhof F, Ciccarelli O, Chard DT, Eshaghi A. Predicting disability progression and cognitive worsening in multiple sclerosis using patterns of grey matter volumes. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 33879535 DOI: 10.1136/jnnp-2020-325610  1
2021 Lopes Alves I, Heeman F, Collij LE, Salvadó G, Tolboom N, Vilor-Tejedor N, Markiewicz P, Yaqub M, Cash D, Mormino EC, Insel PS, Boellaard R, van Berckel BNM, Lammertsma AA, Barkhof F, et al. Strategies to reduce sample sizes in Alzheimer's disease primary and secondary prevention trials using longitudinal amyloid PET imaging. Alzheimer's Research & Therapy. 13: 82. PMID 33875021 DOI: 10.1186/s13195-021-00819-2  1
2021 Schoonheim MM, Pinter D, Prouskas SE, Broeders TA, Pirpamer L, Khalil M, Ropele S, Uitdehaag BM, Barkhof F, Enzinger C, Geurts JJ. Disability in multiple sclerosis is related to thalamic connectivity and cortical network atrophy. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211008743. PMID 33870779 DOI: 10.1177/13524585211008743  1
2021 Eshaghi A, Young AL, Wijeratne PA, Prados F, Arnold DL, Narayanan S, Guttmann CRG, Barkhof F, Alexander DC, Thompson AJ, Chard D, Ciccarelli O. Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data. Nature Communications. 12: 2078. PMID 33824310 DOI: 10.1038/s41467-021-22265-2  1
2021 Collij LE, Ingala S, Top H, Wottschel V, Stickney KE, Tomassen J, Konijnenberg E, Ten Kate M, Sudre C, Lopes Alves I, Yaqub MM, Wink AM, Van 't Ent D, Scheltens P, van Berckel BNM, ... ... Barkhof F, et al. White matter microstructure disruption in early stage amyloid pathology. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12124. PMID 33816751 DOI: 10.1002/dad2.12124  1
2021 Ingala S, De Boer C, Masselink LA, Vergari I, Lorenzini L, Blennow K, Chételat G, Di Perri C, Ewers M, van der Flier WM, Fox NC, Gispert JD, Haller S, Molinuevo JL, Muniz-Terrera G, ... ... Barkhof F, et al. Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33811742 DOI: 10.1002/alz.12292  1
2021 Shi L, Winchester LM, Westwood S, Baird AL, Anand SN, Buckley NJ, Hye A, Ashton NJ, Bos I, Vos SJB, Kate MT, Scheltens P, Teunissen CE, Vandenberghe R, Gabel S, ... ... Barkhof F, et al. Replication study of plasma proteins relating to Alzheimer's pathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33792144 DOI: 10.1002/alz.12322  1
2021 Haider L, Chung K, Birch G, Eshaghi A, Mangesius S, Prados F, Tur C, Ciccarelli O, Barkhof F, Chard D. Linear brain atrophy measures in multiple sclerosis and clinically isolated syndromes: a 30-year follow-up. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 33785581 DOI: 10.1136/jnnp-2020-325421  1
2021 Heeman F, Yaqub M, Hendriks J, Bader I, Barkhof F, Gispert JD, van Berckel BNM, Alves IL, Lammertsma AA. PARAMETRIC IMAGING OF DUAL-TIME-WINDOW [F]FLUTEMETAMOL AND [F]FLORBETABEN STUDIES: Parametric imaging dual-time-window amyloid PET. Neuroimage. 117953. PMID 33762215 DOI: 10.1016/j.neuroimage.2021.117953  1
2021 Sala-Vila A, Arenaza-Urquijo EM, Sánchez-Benavides G, Suárez-Calvet M, Milà-Alomà M, Grau-Rivera O, González-de-Echávarri JM, Crous-Bou M, Minguillón C, Fauria K, Operto G, Falcón C, Salvadó G, Cacciaglia R, Ingala S, ... Barkhof F, et al. DHA intake relates to better cerebrovascular and neurodegeneration neuroimaging phenotypes in middle-aged adults at increased genetic risk of Alzheimer disease. The American Journal of Clinical Nutrition. PMID 33733657 DOI: 10.1093/ajcn/nqab016  1
2021 Duan Y, Zhuo Z, Li H, Tian DC, Li Y, Yang L, Gao C, Zhang T, Zhang X, Shi FD, Barkhof F, Liu Y. Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 33687975 DOI: 10.1136/jnnp-2020-324826  1
2021 Barkhof F, Pressman PS. Early Detection of Incipient Alzheimer Pathology: Time Is of the Essence. Neurology. 96: 647-648. PMID 33653896 DOI: 10.1212/WNL.0000000000011739  0.01
2021 Haller S, Haacke EM, Thurnher MM, Barkhof F. Susceptibility-weighted Imaging: Technical Essentials and Clinical Neurologic Applications. Radiology. 203071. PMID 33620291 DOI: 10.1148/radiol.2021203071  1
2021 Collij LE, Salvadó G, Shekari M, Alves IL, Reimand J, Wink AM, Zwan M, Niñerola-Baizán A, Perissinotti A, Scheltens P, Ikonomovic MD, Smith APL, Farrar G, Molinuevo JL, Barkhof F, et al. Visual assessment of [F]flutemetamol PET images can detect early amyloid pathology and grade its extent. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33615397 DOI: 10.1007/s00259-020-05174-2  1
2021 Markiewicz PJ, Matthews JC, Ashburner J, Cash DM, Thomas DL, Vita E, Barnes A, Cardoso MJ, Modat M, Brown R, Thielemans K, da Costa-Luis C, Alves IL, Lopez JDG, Schmidt M, ... ... Barkhof F, et al. Uncertainty analysis of MR-PET image registration for precision neuro-PET imaging. Neuroimage. 117821. PMID 33588030 DOI: 10.1016/j.neuroimage.2021.117821  1
2021 Coomans EM, Schoonhoven DN, Tuncel H, Verfaillie SCJ, Wolters EE, Boellaard R, Ossenkoppele R, den Braber A, Scheper W, Schober P, Sweeney SP, Ryan JM, Schuit RC, Windhorst AD, Barkhof F, et al. In vivo tau pathology is associated with synaptic loss and altered synaptic function. Alzheimer's Research & Therapy. 13: 35. PMID 33546722 DOI: 10.1186/s13195-021-00772-0  1
2021 Villemagne VL, Barkhof F, Garibotto V, Landau SM, Nordberg A, van Berckel BNM. Molecular Imaging Approaches in Dementia. Radiology. 200028. PMID 33464184 DOI: 10.1148/radiol.2020200028  1
2021 Wagenmakers MJ, Vansteelandt K, van Exel E, Postma R, Schouws SNTM, Obbels J, Rhebergen D, Bouckaert F, Stek ML, Barkhof F, Beekman ATF, Veltman DJ, Sienaert P, Dols A, Oudega ML. Transient Cognitive Impairment and White Matter Hyperintensities in Severely Depressed Older Patients Treated With Electroconvulsive Therapy. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 33454176 DOI: 10.1016/j.jagp.2020.12.028  1
2021 Pemberton HG, Goodkin O, Prados F, Das RK, Vos SB, Moggridge J, Coath W, Gordon E, Barrett R, Schmitt A, Whiteley-Jones H, Burd C, Wattjes MP, Haller S, Vernooij MW, ... ... Barkhof F, et al. Automated quantitative MRI volumetry reports support diagnostic interpretation in dementia: a multi-rater, clinical accuracy study. European Radiology. PMID 33452627 DOI: 10.1007/s00330-020-07455-8  1
2021 Rocca MA, Valsasina P, Meani A, Gobbi C, Zecca C, Rovira A, Sastre-Garriga J, Kearney H, Ciccarelli O, Matthews L, Palace J, Gallo A, Bisecco A, Lukas C, Bellenberg B, ... Barkhof F, et al. Association of Gray Matter Atrophy Patterns with Clinical Phenotype and Progression in Multiple Sclerosis. Neurology. PMID 33441452 DOI: 10.1212/WNL.0000000000011494  1
2021 Chard DT, Alahmadi AAS, Audoin B, Charalambous T, Enzinger C, Hulst HE, Rocca MA, Rovira À, Sastre-Garriga J, Schoonheim MM, Tijms B, Tur C, Gandini Wheeler-Kingshott CAM, Wink AM, Ciccarelli O, ... Barkhof F, et al. Mind the gap: from neurons to networks to outcomes in multiple sclerosis. Nature Reviews. Neurology. PMID 33437067 DOI: 10.1038/s41582-020-00439-8  1
2021 Erkoyun HU, van der Lee SJ, Nijmeijer B, Spaendonk RV, Nelissen A, Scarioni M, Dijkstra A, Samancı B, Gürvit H, Yıldırım Z, Tepgeç F, Bilgic B, Barkhof F, Rozemuller A, van der Flier WM, et al. The Right Temporal Variant of Frontotemporal Dementia is Not Genetically Sporadic: A Case Series. Journal of Alzheimer's Disease : Jad. PMID 33427744 DOI: 10.3233/JAD-201191  1
2021 Pelkmans W, Legdeur N, Ten Kate M, Barkhof F, Yaqub MM, Holstege H, van Berckel BNM, Scheltens P, van der Flier WM, Visser PJ, Tijms BM. Amyloid-β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest-old. Annals of Clinical and Translational Neurology. PMID 33421355 DOI: 10.1002/acn3.51273  1
2021 van Maurik IS, Rhodius-Meester HFM, Teunissen CE, Scheltens P, Barkhof F, Palmqvist S, Hansson O, van der Flier WM, Berkhof J. Biomarker testing in MCI patients-deciding who to test. Alzheimer's Research & Therapy. 13: 14. PMID 33413634 DOI: 10.1186/s13195-020-00763-7  1
2021 Zhuo Z, Li Y, Duan Y, Cao G, Zheng F, Ding J, Tian D, Wang X, Wang J, Zhang X, Li K, Zhou F, Huang M, Li Y, Li H, ... ... Barkhof F, et al. Subtyping relapsing-remitting multiple sclerosis using structural MRI. Journal of Neurology. PMID 33387013 DOI: 10.1007/s00415-020-10376-7  1
2020 Eijgelaar RS, Visser M, Müller DMJ, Barkhof F, Vrenken H, van Herk M, Bello L, Conti Nibali M, Rossi M, Sciortino T, Berger MS, Hervey-Jumper S, Kiesel B, Widhalm G, Furtner J, et al. Robust Deep Learning-based Segmentation of Glioblastoma on Routine Clinical MRI Scans Using Sparsified Training. Radiology. Artificial Intelligence. 2: e190103. PMID 33937837 DOI: 10.1148/ryai.2020190103  1
2020 Tijms BM, Gobom J, Reus L, Jansen I, Hong S, Dobricic V, Kilpert F, Ten Kate M, Barkhof F, Tsolaki M, Verhey FRJ, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, et al. Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics. Brain : a Journal of Neurology. 143: 3776-3792. PMID 33439986 DOI: 10.1093/brain/awaa325  1
2020 Dekker I, Schoonheim MM, Venkatraghavan V, Eijlers AJC, Brouwer I, Bron EE, Klein S, Wattjes MP, Wink AM, Geurts JJG, Uitdehaag BMJ, Oxtoby NP, Alexander DC, Vrenken H, Killestein J, ... Barkhof F, et al. The sequence of structural, functional and cognitive changes in multiple sclerosis. Neuroimage. Clinical. 29: 102550. PMID 33418173 DOI: 10.1016/j.nicl.2020.102550  1
2020 Goodkin O, Prados F, Vos SB, Pemberton H, Collorone S, Hagens MHJ, Cardoso MJ, Yousry TA, Thornton JS, Sudre CH, Barkhof F. FLAIR-only joint volumetric analysis of brain lesions and atrophy in clinically isolated syndrome (CIS) suggestive of multiple sclerosis. Neuroimage. Clinical. 29: 102542. PMID 33418171 DOI: 10.1016/j.nicl.2020.102542  1
2020 Burggraaff J, Liu Y, Prieto JC, Simoes J, de Sitter A, Ruggieri S, Brouwer I, Lissenberg-Witte BI, Rocca MA, Valsasina P, Ropele S, Gasperini C, Gallo A, Pareto D, Sastre-Garriga J, ... ... Barkhof F, et al. Manual and automated tissue segmentation confirm the impact of thalamus atrophy on cognition in multiple sclerosis: A multicenter study. Neuroimage. Clinical. 29: 102549. PMID 33401136 DOI: 10.1016/j.nicl.2020.102549  1
2020 Dicks E, Vermunt L, van der Flier WM, Barkhof F, Scheltens P, Tijms BM. Grey matter network trajectories across the Alzheimer's disease continuum and relation to cognition. Brain Communications. 2: fcaa177. PMID 33376987 DOI: 10.1093/braincomms/fcaa177  1
2020 Filippi M, Preziosa P, Barkhof F, Chard DT, De Stefano N, Fox RJ, Gasperini C, Kappos L, Montalban X, Moraal B, Reich DS, Rovira À, Toosy AT, Traboulsee A, Weinshenker BG, et al. Diagnosis of Progressive Multiple Sclerosis From the Imaging Perspective: A Review. Jama Neurology. PMID 33315071 DOI: 10.1001/jamaneurol.2020.4689  1
2020 Weeda MM, Pruis IJ, Westerveld ASR, Brouwer I, Bellenberg B, Barkhof F, Vrenken H, Lukas C, Schneider R, Pouwels PJW. Damage in the Thalamocortical Tracts is Associated With Subsequent Thalamus Atrophy in Early Multiple Sclerosis. Frontiers in Neurology. 11: 575611. PMID 33281710 DOI: 10.3389/fneur.2020.575611  1
2020 Sormani MP, Tur C, Barkhof F. Ibudilast: a paradigm shift for progressive MS? Neurology. PMID 33268561 DOI: 10.1212/WNL.0000000000011312  1
2020 Wijburg MT, Warnke C, McGuigan C, Koralnik IJ, Barkhof F, Killestein J, Wattjes MP. Pharmacovigilance during treatment of multiple sclerosis: early recognition of CNS complications. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 33229453 DOI: 10.1136/jnnp-2020-324534  1
2020 Hong S, Prokopenko D, Dobricic V, Kilpert F, Bos I, Vos SJB, Tijms BM, Andreasson U, Blennow K, Vandenberghe R, Cleynen I, Gabel S, Schaeverbeke J, Scheltens P, Teunissen CE, ... ... Barkhof F, et al. Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset. Translational Psychiatry. 10: 403. PMID 33223526 DOI: 10.1038/s41398-020-01074-z  1
2020 Ribaldi F, Altomare D, Jovicich J, Ferrari C, Picco A, Pizzini FB, Soricelli A, Mega A, Ferretti A, Drevelegas A, Bosch B, Müller BW, Marra C, Cavaliere C, Bartrés-Faz D, ... ... Barkhof F, et al. Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study. Magnetic Resonance Imaging. PMID 33220450 DOI: 10.1016/j.mri.2020.11.008  1
2020 Singleton EH, Pijnenburg YAL, Sudre CH, Groot C, Kochova E, Barkhof F, La Joie R, Rosen HJ, Seeley WW, Miller B, Cardoso MJ, Papma J, Scheltens P, Rabinovici GD, Ossenkoppele R. Investigating the clinico-anatomical dissociation in the behavioral variant of Alzheimer disease. Alzheimer's Research & Therapy. 12: 148. PMID 33189136 DOI: 10.1186/s13195-020-00717-z  1
2020 Saslow L, Li DKB, Halper J, Banwell B, Barkhof F, Barlow L, Costello K, Damiri P, Dunn J, Giri S, Maes M, Morrow SA, Newsome SD, Oh J, Paul F, et al. An International Standardized Magnetic Resonance Imaging Protocol for Diagnosis and Follow-up of Patients with Multiple Sclerosis: Advocacy, Dissemination, and Implementation Strategies. International Journal of Ms Care. 22: 226-232. PMID 33177959 DOI: 10.7224/1537-2073.2020-094  1
2020 Solanky BS, John NA, DeAngelis F, Stutters J, Prados F, Schneider T, Parker RA, Weir CJ, Monteverdi A, Plantone D, Doshi A, MacManus D, Marshall I, Barkhof F, Gandini Wheeler-Kingshott CAM, et al. NAA is a Marker of Disability in Secondary-Progressive MS: A Proton MR Spectroscopic Imaging Study. Ajnr. American Journal of Neuroradiology. PMID 33154071 DOI: 10.3174/ajnr.A6809  1
2020 Lam KH, Meijer KA, Loonstra FC, Coerver E, Twose J, Redeman E, Moraal B, Barkhof F, de Groot V, Uitdehaag B, Killestein J. Real-world keystroke dynamics are a potentially valid biomarker for clinical disability in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520968797. PMID 33150823 DOI: 10.1177/1352458520968797  1
2020 Chételat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, van de Giessen E, Agosta F, Barkhof F, Brooks DJ, Carrillo MC, Dubois B, Fjell AM, Frisoni GB, Hansson O, et al. Amyloid-PET and F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias. The Lancet. Neurology. 19: 951-962. PMID 33098804 DOI: 10.1016/S1474-4422(20)30314-8  1
2020 van Duinkerken E, Bernardes G, van Bloemendaal L, Veltman DJ, Barkhof F, Mograbi DC, Gerdes VEA, Deacon CF, Holst JJ, Drent ML, Diamant M, Ten Kulve J, Ijzerman RG. Cerebral effects of glucagon-like peptide-1 receptor blockade before and after Roux-en-Y gastric bypass surgery in obese women: A proof-of-concept resting-state functional MRI study. Diabetes, Obesity & Metabolism. PMID 33084088 DOI: 10.1111/dom.14233  1
2020 Zhuo Z, Duan Y, Tian D, Wang X, Gao C, Ding J, Zheng F, Zhang T, Zhang X, Barkhof F, Shi FD, Liu Y. Brain structural and functional alterations in MOG antibody disease. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520964415. PMID 33054621 DOI: 10.1177/1352458520964415  1
2020 Leeuwis AE, Hooghiemstra AM, Bron EE, Kuipers S, Oudeman EA, Kalay T, Brunner-La Rocca HP, Kappelle LJ, van Oostenbrugge RJ, Greving JP, Niessen WJ, van Buchem MA, van Osch MJP, van Rossum AC, Prins ND, ... ... Barkhof F, et al. Cerebral blood flow and cognitive functioning in patients with disorders along the heart-brain axis: Cerebral blood flow and the heart-brain axis. Alzheimer's & Dementia (New York, N. Y.). 6: e12034. PMID 32995468 DOI: 10.1002/Trc2.12034  1
2020 Verberk IMW, Thijssen E, Koelewijn J, Mauroo K, Vanbrabant J, de Wilde A, Zwan MD, Verfaillie SCJ, Ossenkoppele R, Barkhof F, van Berckel BNM, Scheltens P, van der Flier WM, Stoops E, Vanderstichele HM, et al. Combination of plasma amyloid beta and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology. Alzheimer's Research & Therapy. 12: 118. PMID 32988409 DOI: 10.1186/s13195-020-00682-7  1
2020 Calvi A, Haider L, Prados F, Tur C, Chard D, Barkhof F. In vivo imaging of chronic active lesions in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520958589. PMID 32965168 DOI: 10.1177/1352458520958589  1
2020 Moccia M, Valsecchi N, Ciccarelli O, Van Schijndel R, Barkhof F, Prados F. Spinal cord atrophy in a primary progressive multiple sclerosis trial: Improved sample size using GBSI. Neuroimage. Clinical. 28: 102418. PMID 32961403 DOI: 10.1016/J.Nicl.2020.102418  1
2020 Moccia M, van de Pavert S, Eshaghi A, Haider L, Pichat J, Yiannakas M, Ourselin S, Wang Y, Wheeler-Kingshott C, Thompson A, Barkhof F, Ciccarelli O. Pathological correlates of the magnetization transfer ratio in multiple sclerosis. Neurology. PMID 32938787 DOI: 10.1212/Wnl.0000000000010909  1
2020 Legdeur N, Badissi M, Yaqub M, Beker N, Sudre CH, Ten Kate M, Gordon MF, Novak G, Barkhof F, van Berckel BNM, Holstege H, Muller M, Scheltens P, Maier AB, Visser PJ. What determines cognitive functioning in the oldest-old? The EMIF-AD 90+ Study. The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. PMID 32898275 DOI: 10.1093/Geronb/Gbaa152  1
2020 Bouman PM, Steenwijk MD, Pouwels PJW, Schoonheim MM, Barkhof F, Jonkman LE, Geurts JJG. Histopathology-validated recommendations for cortical lesion imaging in multiple sclerosis. Brain : a Journal of Neurology. PMID 32889535 DOI: 10.1093/Brain/Awaa233  1
2020 Ebenau JL, Verfaillie SCJ, van den Bosch KA, Timmers T, Wesselman LMP, van Leeuwenstijn M, Tuncel H, Golla SVS, Yaqub MM, Windhorst AD, Prins ND, Barkhof F, Scheltens P, van der Flier WM, van Berckel BNM. Grey zone amyloid burden affects memory function: the SCIENCe project. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32888039 DOI: 10.1007/s00259-020-05012-5  1
2020 de Leeuw FA, Karamujić-Čomić H, Tijms BM, Peeters CFW, Kester MI, Scheltens P, Ahmad S, Vojinovic D, Adams HHH, Hankemeier T, Bos D, van der Lugt A, Vernooij MW, Ikram MA, Amin N, ... Barkhof F, et al. Circulating metabolites are associated with brain atrophy and white matter hyperintensities. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32886448 DOI: 10.1002/Alz.12180  1
2020 Exalto LG, Boomsma JMF, Babapour Mofrad R, Barkhof F, Groeneveld ON, Heinen R, Kuijf HJ, Leeuwis AE, Prins ND, Biessels GJ, Vd Flier WM. Sex differences in memory clinic patients with possible vascular cognitive impairment. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12090. PMID 32875057 DOI: 10.1002/Dad2.12090  1
2020 Shi L, Winchester LM, Liu BY, Killick R, Ribe EM, Westwood S, Baird AL, Buckley NJ, Hong S, Dobricic V, Kilpert F, Franke A, Kiddle S, Sattlecker M, Dobson R, ... ... Barkhof F, et al. Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology. Journal of Alzheimer's Disease : Jad. PMID 32831200 DOI: 10.3233/Jad-200208  1
2020 Ulugut Erkoyun H, Groot C, Heilbron R, Nelissen A, van Rossum J, Jutten R, Koene T, van der Flier WM, Wattjes MP, Scheltens P, Ossenkoppele R, Barkhof F, Pijnenburg Y. A clinical-radiological framework of the right temporal variant of frontotemporal dementia. Brain : a Journal of Neurology. PMID 32830218 DOI: 10.1093/Brain/Awaa225  1
2020 Gerdes LA, Janoschka C, Eveslage M, Mannig B, Wirth T, Schulte-Mecklenbeck A, Lauks S, Glau L, Gross CC, Tolosa E, Flierl-Hecht A, Ertl-Wagner B, Barkhof F, Meuth SG, Kümpfel T, et al. Immune signatures of prodromal multiple sclerosis in monozygotic twins. Proceedings of the National Academy of Sciences of the United States of America. 117: 21546-21556. PMID 32817525 DOI: 10.1073/Pnas.2003339117  1
2020 Frisoni GB, Molinuevo JL, Altomare D, Carrera E, Barkhof F, Berkhof J, Delrieu J, Dubois B, Kivipelto M, Nordberg A, Schott JM, van der Flier WM, Vellas B, Jessen F, Scheltens P, et al. Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32815289 DOI: 10.1002/Alz.12132  1
2020 Verhaar BJH, de Leeuw FA, Doorduijn AS, Fieldhouse JLP, van de Rest O, Teunissen CE, van Berckel BNM, Barkhof F, Visser M, de van der Schueren MAE, Scheltens P, Kester MI, Muller M, van der Flier WM. Nutritional status and structural brain changes in Alzheimer's disease: The NUDAD project. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12063. PMID 32793798 DOI: 10.1002/Dad2.12063  1
2020 Ingala S, Mazzai L, Sudre CH, Salvadó G, Brugulat-Serrat A, Wottschel V, Falcon C, Operto G, Tijms B, Gispert JD, Molinuevo JL, Barkhof F. The relation between APOE genotype and cerebral microbleeds in cognitively unimpaired middle- and old-aged individuals. Neurobiology of Aging. 95: 104-114. PMID 32791423 DOI: 10.1016/J.Neurobiolaging.2020.06.015  1
2020 Boomsma JMF, Exalto LG, Barkhof F, Chen CLH, Hilal S, Leeuwis AE, Prins ND, Saridin FN, Scheltens P, Teunissen CE, Verwer JH, Weinstein HC, van der Flier WM, Biessels GJ. Prediction of poor clinical outcome in vascular cognitive impairment: TRACE-VCI study. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12077. PMID 32789162 DOI: 10.1002/Dad2.12077  1
2020 Mofrad RB, Tijms BM, Scheltens P, Barkhof F, van der Flier WM, Am Sikkes S, Teunissen CE. Sex differences in CSF biomarkers vary by Alzheimer's disease stage and APOE ε4 genotype. Neurology. PMID 32788242 DOI: 10.1212/Wnl.0000000000010629  1
2020 Geraldes R, Juryńczyk M, Dos Passos GR, Pichler A, Chung K, Hagens M, Ruggieri S, Auger C, Sastre-Garriga J, Enzinger C, Chard D, Barkhof F, Gasperini C, Rovira A, DeLuca G, et al. The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520943777. PMID 32757905 DOI: 10.1177/1352458520943777  1
2020 Alexander S, Peryer G, Gray E, Barkhof F, Chataway J. Wearable technologies to measure clinical outcomes in multiple sclerosis: A scoping review. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520946005. PMID 32749928 DOI: 10.1177/1352458520946005  1
2020 Goodkin O, Pemberton HG, Vos SB, Prados F, Das RK, Moggridge J, De Blasi B, Bartlett P, Williams E, Campion T, Haider L, Pearce K, Bargallό N, Sanchez E, Bisdas S, ... ... Barkhof F, et al. Clinical evaluation of automated quantitative MRI reports for assessment of hippocampal sclerosis. European Radiology. PMID 32749588 DOI: 10.1007/S00330-020-07075-2  1
2020 Heinen R, Groeneveld ON, Barkhof F, de Bresser J, Exalto LG, Kuijf HJ, Prins ND, Scheltens P, van der Flier WM, Biessels GJ. Small vessel disease lesion type and brain atrophy: The role of co-occurring amyloid. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12060. PMID 32695872 DOI: 10.1002/Dad2.12060  1
2020 van Kempen ZLE, Hoogervorst ELJ, Wattjes MP, Kalkers NF, Mostert JP, Lissenberg-Witte BI, de Vries A, Brinke AT, van Oosten BW, Barkhof F, Teunissen CE, Uitdehaag BMJ, Rispens T, Killestein J. Personalized extended interval dosing of natalizumab in MS- a prospective multicenter trial. Neurology. PMID 32690785 DOI: 10.1212/Wnl.0000000000009995  1
2020 Groot C, Yeo BTT, Vogel JW, Zhang X, Sun N, Mormino EC, Pijnenburg YAL, Miller BL, Rosen HJ, Joie R, Barkhof F, Scheltens P, van der Flier WM, Rabinovici GD, Ossenkoppele R. Latent atrophy factors related to phenotypical variants of posterior cortical atrophy. Neurology. PMID 32675078 DOI: 10.1212/Wnl.0000000000010362  1
2020 Jonkman LE, Steenwijk MD, Boesen N, Rozemuller AJM, Barkhof F, Geurts JJG, Douw L, van de Berg WDJ. Relationship between β-amyloid and structural network topology in decedents without dementia. Neurology. PMID 32661099 DOI: 10.1212/Wnl.0000000000009910  1
2020 Giovannoni G, Knappertz V, Steinerman JR, Tansy AP, Li T, Krieger S, Uccelli A, Uitdehaag BMJ, Montalban X, Hartung HP, Sormani MP, Cree BAC, Lublin F, Barkhof F. A randomized, placebo-controlled phase 2 trial of laquinimod in primary progressive multiple sclerosis. Neurology. PMID 32651286 DOI: 10.1212/Wnl.0000000000010284  1
2020 de Sitter A, Verhoeven T, Burggraaff J, Liu Y, Simoes J, Ruggieri S, Palotai M, Brouwer I, Versteeg A, Wottschel V, Ropele S, Rocca MA, Gasperini C, Gallo A, Yiannakas MC, ... ... Barkhof F, et al. Reduced accuracy of MRI deep grey matter segmentation in multiple sclerosis: an evaluation of four automated methods against manual reference segmentations in a multi-center cohort. Journal of Neurology. PMID 32621103 DOI: 10.1007/S00415-020-10023-1  1
2020 Dicks E, van der Flier WM, Scheltens P, Barkhof F, Tijms BM. Single-subject gray matter networks predict future cortical atrophy in preclinical Alzheimer's disease. Neurobiology of Aging. 94: 71-80. PMID 32585492 DOI: 10.1016/J.Neurobiolaging.2020.05.008  1
2020 Visser M, Petr J, Müller DMJ, Eijgelaar RS, Hendriks EJ, Witte M, Barkhof F, van Herk M, Mutsaerts HJMM, Vrenken H, de Munck JC, De Witt Hamer PC. Accurate MR Image Registration to Anatomical Reference Space for Diffuse Glioma. Frontiers in Neuroscience. 14: 585. PMID 32581699 DOI: 10.3389/Fnins.2020.00585  1
2020 Alexander N, Alexander DC, Barkhof F, Denaxas S. Using Unsupervised Learning to Identify Clinical Subtypes of Alzheimer's Disease in Electronic Health Records. Studies in Health Technology and Informatics. 270: 499-503. PMID 32570434 DOI: 10.3233/SHTI200210  0.01
2020 van Faals NL, Dekker I, Balk LJ, Moraal B, Barkhof F, Uitdehaag BMJ, Killestein J, Wattjes MP. Clinico-radiological dissociation of disease activity in MS patients: frequency and clinical relevance. Journal of Neurology. PMID 32564152 DOI: 10.1007/S00415-020-09991-1  1
2020 Mutsaerts HJMM, Petr J, Groot P, Vandemaele P, Ingala S, Robertson AD, Václavů L, Groote I, Kuijf H, Zelaya F, O'Daly O, Hilal S, Wink AM, Kant I, Caan MWA, ... ... Barkhof F, et al. ExploreASL: an image processing pipeline for multi-center ASL perfusion MRI studies. Neuroimage. 117031. PMID 32526385 DOI: 10.1016/J.Neuroimage.2020.117031  1
2020 Ebenau JL, Timmers T, Wesselman LMP, Verberk IMW, Verfaillie SCJ, Slot RER, van Harten AC, Teunissen CE, Barkhof F, van den Bosch KA, van Leeuwenstijn M, Tomassen J, Braber AD, Visser PJ, Prins ND, et al. ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project. Neurology. PMID 32522798 DOI: 10.1212/Wnl.0000000000009724  1
2020 Chataway J, De Angelis F, Connick P, Parker RA, Doshi A, John N, Barkhof F, Sharrack B, Weir CJ, Chandran S. MS-SMART study: systematic sampling bias concerns - Authors' reply. The Lancet. Neurology. 19: 479-480. PMID 32470412 DOI: 10.1016/S1474-4422(20)30149-6  1
2020 Quattrini G, Pievani M, Jovicich J, Aiello M, Bargalló N, Barkhof F, Bartres-Faz D, Beltramello A, Pizzini FB, Blin O, Bordet R, Caulo M, Constantinides M, Didic M, Drevelegas A, et al. Amygdalar nuclei and hippocampal subfields on MRI: test-retest reliability of automated volumetry across different MRI sites and vendors. Neuroimage. 116932. PMID 32416226 DOI: 10.1016/J.Neuroimage.2020.116932  1
2020 Cole JH, Raffel J, Friede T, Eshaghi A, Brownlee WJ, Chard D, De Stefano N, Enzinger C, Pirpamer L, Filippi M, Gasperini C, Rocca MA, Rovira A, Ruggieri S, Sastre-Garriga J, ... ... Barkhof F, et al. Longitudinal assessment of multiple sclerosis with the brain-age paradigm. Annals of Neurology. PMID 32285956 DOI: 10.1002/Ana.25746  1
2020 Lopes Alves I, Collij LE, Altomare D, Frisoni GB, Saint-Aubert L, Payoux P, Kivipelto M, Jessen F, Drzezga A, Leeuwis A, Wink AM, Visser PJ, van Berckel BNM, Scheltens P, Gray KR, ... ... Barkhof F, et al. Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32281303 DOI: 10.1002/Alz.12069  1
2020 Pitkänen J, Koikkalainen J, Nieminen T, Marinkovic I, Curtze S, Sibolt G, Jokinen H, Rueckert D, Barkhof F, Schmidt R, Pantoni L, Scheltens P, Wahlund LO, Korvenoja A, Lötjönen J, et al. Evaluating severity of white matter lesions from computed tomography images with convolutional neural network. Neuroradiology. PMID 32281028 DOI: 10.1007/S00234-020-02410-2  1
2020 Müller DMJ, Robe PA, Ardon H, Barkhof F, Bello L, Berger MS, Bouwknegt W, Van den Brink WA, Conti Nibali M, Eijgelaar RS, Furtner J, Han SJ, Hervey-Jumper SL, Idema AJS, Kiesel B, et al. Quantifying eloquent locations for glioblastoma surgery using resection probability maps. Journal of Neurosurgery. 1-11. PMID 32244208 DOI: 10.3171/2020.1.Jns193049  1
2020 Bot JCJ, Mazzai L, Hagenbeek RE, Ingala S, van Oosten B, Sanchez-Aliaga E, Barkhof F. Response: Brain miliary enhancement. Neuroradiology. PMID 32215682 DOI: 10.1007/S00234-020-02404-0  1
2020 Sastre-Garriga J, Pareto D, Battaglini M, Rocca MA, Ciccarelli O, Enzinger C, Wuerfel J, Sormani MP, Barkhof F, Yousry TA, De Stefano N, Tintoré M, Filippi M, Gasperini C, Kappos L, et al. MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice. Nature Reviews. Neurology. 16: 171-182. PMID 32094485 DOI: 10.1038/S41582-020-0314-X  1
2020 Ferro DA, van den Brink H, Exalto LG, Boomsma JMF, Barkhof F, Prins ND, van der Flier WM, Biessels GJ. Author response: Clinical relevance of acute cerebral microinfarcts in vascular cognitive impairment. Neurology. 94: 330. PMID 32066642 DOI: 10.1212/Wnl.0000000000008974  1
2020 van de Beek M, van Steenoven I, van der Zande JJ, Barkhof F, Teunissen CE, van der Flier WM, Lemstra AW. Prodromal Dementia with Lewy Bodies: Clinical Characterization and Predictors of Progression. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32048343 DOI: 10.1002/Mds.27997  1
2020 Oudega ML, Siddiqui A, Wattjes MP, Barkhof F, Kate MT, Muller M, Bouckaert F, Vandenbulcke M, De Winter FL, Sienaert P, Stek ML, Comijs HC, Korten NCM, Emsell L, Eikelenboom P, et al. Are Apathy and Depressive Symptoms Related to Vascular White Matter Hyperintensities in Severe Late Life Depression? Journal of Geriatric Psychiatry and Neurology. 891988720901783. PMID 32036772 DOI: 10.1177/0891988720901783  1
2020 Geraldes R, Juryńczyk M, Dos Passos G, Prichler A, Chung K, Hagens M, Ruggieri S, Huerga E, Sastre-Garriga J, Enzinger C, Chard DT, Barkhof F, Gasperini C, Rovira A, DeLuca GC, et al. Distinct influence of different vascular risk factors on white matter brain lesions in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32034114 DOI: 10.1136/Jnnp-2019-322369  1
2020 Westwood S, Baird AL, Anand SN, Nevado-Holgado AJ, Kormilitzin A, Shi L, Hye A, Ashton NJ, Morgan AR, Bos I, Vos SJB, Baker S, Buckley NJ, Ten Kate M, Scheltens P, ... ... Barkhof F, et al. Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort. Journal of Alzheimer's Disease : Jad. PMID 31985466 DOI: 10.3233/Jad-190434  1
2020 Chataway J, De Angelis F, Connick P, Parker RA, Plantone D, Doshi A, John N, Stutters J, MacManus D, Prados Carrasco F, Barkhof F, Ourselin S, Braisher M, Ross M, Cranswick G, et al. Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial. The Lancet. Neurology. PMID 31981516 DOI: 10.1016/S1474-4422(19)30485-5  1
2020 Cortese R, Tur C, Prados F, Schneider T, Kanber B, Moccia M, Wheeler-Kingshott CAG, Thompson AJ, Barkhof F, Ciccarelli O. Ongoing microstructural changes in the cervical cord underpin disability progression in early primary progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519900971. PMID 31961242 DOI: 10.1177/1352458519900971  1
2020 Rhodius-Meester HFM, van Maurik IS, Koikkalainen J, Tolonen A, Frederiksen KS, Hasselbalch SG, Soininen H, Herukka SK, Remes AM, Teunissen CE, Barkhof F, Pijnenburg YAL, Scheltens P, Lötjönen J, van der Flier WM. Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy. Plos One. 15: e0226784. PMID 31940390 DOI: 10.1371/Journal.Pone.0226784  1
2020 Bot JCJ, Mazzai L, Hagenbeek RE, Ingala S, van Oosten B, Sanchez-Aliaga E, Barkhof F. Brain miliary enhancement. Neuroradiology. PMID 31925469 DOI: 10.1007/S00234-019-02335-5  1
2020 Leijenaar JF, Groeneveld GJ, Klaassen ES, Leeuwis AE, Scheltens P, Weinstein HC, van Gerven JMA, Barkhof F, van der Flier WM, Prins ND. Methylphenidate and galantamine in patients with vascular cognitive impairment-the proof-of-principle study STREAM-VCI. Alzheimer's Research & Therapy. 12: 10. PMID 31910895 DOI: 10.1186/S13195-019-0567-Z  1
2019 Boon BDC, Pouwels PJW, Jonkman LE, Keijzer MJ, Preziosa P, van de Berg WDJ, Geurts JJG, Scheltens P, Barkhof F, Rozemuller AJM, Bouwman FH, Steenwijk MD. Can MRI be used as a proxy for ? A case study. Brain Communications. 1: fcz030. PMID 32954270 DOI: 10.1093/braincomms/fcz030  1
2019 Marinescu RV, Oxtoby NP, Young AL, Bron EE, Toga AW, Weiner MW, Barkhof F, Fox NC, Golland P, Klein S, Alexander DC. TADPOLE Challenge: Accurate Alzheimer's disease prediction through crowdsourced forecasting of future data. Predictive Intelligence in Medicine : Second International Workshop, Prime 2019, Held in Conjunction With Miccai 2019, Shenzhen, China, October 13, 2019, Proceedings. Prime (Workshop) (2nd : 2019 : Shenzhen Shi, China). 11843: 1-10. PMID 32587957 DOI: 10.1007/978-3-030-32281-6_1  1
2019 Marizzoni M, Ferrari C, Babiloni C, Albani D, Barkhof F, Cavaliere L, Didic M, Forloni G, Fusco F, Galluzzi S, Hensch T, Jovicich J, Marra C, Molinuevo JL, Nobili F, et al. CSF cutoffs for MCI due to AD depend on APOEε4 carrier status. Neurobiology of Aging. PMID 32029236 DOI: 10.1016/J.Neurobiolaging.2019.12.019  1
2019 Prados F, Moccia M, Johnson A, Yiannakas M, Grussu F, Cardoso MJ, Ciccarelli O, Ourselin S, Barkhof F, Wheeler-Kingshott C. Generalised boundary shift integral for longitudinal assessment of spinal cord atrophy. Neuroimage. 116489. PMID 31877375 DOI: 10.1016/J.Neuroimage.2019.116489  1
2019 Vos SB, Winston GP, Goodkin O, Pemberton HG, Barkhof F, Prados F, Galovic M, Koepp M, Ourselin S, Cardoso MJ, Duncan JS. Hippocampal profiling: Localized magnetic resonance imaging volumetry and T2 relaxometry for hippocampal sclerosis. Epilepsia. PMID 31872873 DOI: 10.1111/Epi.16416  1
2019 Reimand J, de Wilde A, Teunissen CE, Zwan M, Windhorst AD, Boellaard R, Barkhof F, van der Flier WM, Scheltens P, van Berckel BNM, Ossenkoppele R, Bouwman F. PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases. Alzheimer's Research & Therapy. 11: 100. PMID 31810489 DOI: 10.1186/S13195-019-0561-5  1
2019 Reimand J, Groot C, Teunissen CE, Windhorst AD, Boellaard R, Barkhof F, Nazarenko S, van der Flier WM, van Berckel BNM, Scheltens P, Ossenkoppele R, Bouwman F. Why Is Amyloid-β PET Requested After Performing Cerebrospinal Fluid Biomarkers? Journal of Alzheimer's Disease : Jad. PMID 31796674 DOI: 10.3233/Jad-190836  1
2019 Garbarino S, Lorenzi M, Oxtoby NP, Vinke EJ, Marinescu RV, Eshaghi A, Ikram MA, Niessen WJ, Ciccarelli O, Barkhof F, Schott JM, Vernooij MW, Alexander DC. Differences in topological progression profile among neurodegenerative diseases from imaging data. Elife. 8. PMID 31793876 DOI: 10.7554/Elife.49298  1
2019 Leijenaar JF, Groot C, Sudre CH, Bergeron D, Leeuwis AE, Cardoso MJ, Carrasco FP, Laforce R, Barkhof F, van der Flier WM, Scheltens P, Prins ND, Ossenkoppele R. Comorbid amyloid-β pathology affects clinical and imaging features in VCD. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31786129 DOI: 10.1016/J.Jalz.2019.08.190  1
2019 Brugulat-Serrat A, Salvadó G, Operto G, Cacciaglia R, Sudre CH, Grau-Rivera O, Suárez-Calvet M, Falcon C, Sánchez-Benavides G, Gramunt N, Minguillon C, Fauria K, Barkhof F, Molinuevo JL, Gispert JD, et al. White matter hyperintensities mediate gray matter volume and processing speed relationship in cognitively unimpaired participants. Human Brain Mapping. PMID 31778002 DOI: 10.1002/Hbm.24877  1
2019 Canas LS, Sudre CH, De Vita E, Nihat A, Mok TH, Slattery CF, Paterson RW, Foulkes AJM, Hyare H, Cardoso MJ, Thornton J, Schott JM, Barkhof F, Collinge J, Ourselin S, et al. Prion disease diagnosis using subject-specific imaging biomarkers within a multi-kernel Gaussian process. Neuroimage. Clinical. 24: 102051. PMID 31734530 DOI: 10.1016/J.Nicl.2019.102051  1
2019 Wottschel V, Chard DT, Enzinger C, Filippi M, Frederiksen JL, Gasperini C, Giorgio A, Rocca MA, Rovira A, De Stefano N, Tintoré M, Alexander DC, Barkhof F, Ciccarelli O. SVM recursive feature elimination analyses of structural brain MRI predicts near-term relapses in patients with clinically isolated syndromes suggestive of multiple sclerosis. Neuroimage. Clinical. 24: 102011. PMID 31734524 DOI: 10.1016/J.Nicl.2019.102011  1
2019 Heinen R, Steenwijk MD, Barkhof F, Biesbroek JM, van der Flier WM, Kuijf HJ, Prins ND, Vrenken H, Biessels GJ, de Bresser J. Performance of five automated white matter hyperintensity segmentation methods in a multicenter dataset. Scientific Reports. 9: 16742. PMID 31727919 DOI: 10.1038/S41598-019-52966-0  1
2019 Hagens MHJ, Golla SSV, Janssen B, Vugts DJ, Beaino W, Windhorst AD, O'Brien-Brown J, Kassiou M, Schuit RC, Schwarte LA, de Vries HE, Killestein J, Barkhof F, van Berckel BNM, Lammertsma AA. The P2X receptor tracer [C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31705174 DOI: 10.1007/S00259-019-04550-X  1
2019 Jokinen H, Koikkalainen J, Laakso HM, Melkas S, Nieminen T, Brander A, Korvenoja A, Rueckert D, Barkhof F, Scheltens P, Schmidt R, Fazekas F, Madureira S, Verdelho A, Wallin A, et al. Global Burden of Small Vessel Disease-Related Brain Changes on MRI Predicts Cognitive and Functional Decline. Stroke. STROKEAHA119026170. PMID 31699021 DOI: 10.1161/Strokeaha.119.026170  1
2019 Chung KK, Altmann D, Barkhof F, Miszkiel K, Brex PA, O'Riordan J, Ebner M, Prados F, Cardoso MJ, Vercauteren T, Ourselin S, Thompson A, Ciccarelli O, Chard DT. A thirty year clinical and MRI observational study of multiple sclerosis and clinically isolated syndromes. Annals of Neurology. PMID 31693200 DOI: 10.1002/Ana.25637  1
2019 Jovicich J, Barkhof F, Babiloni C, Herholz K, Mulert C, van Berckel BNM, Frisoni GB. Harmonization of neuroimaging biomarkers for neurodegenerative diseases: A survey in the imaging community of perceived barriers and suggested actions. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 69-73. PMID 31673595 DOI: 10.1016/J.Dadm.2018.11.005  1
2019 Scheltens NME, Briels CT, Yaqub M, Barkhof F, Boellaard R, van der Flier WM, Schwarte LA, Teunissen CE, Attali A, Broersen LM, van Berckel BNM, Scheltens P. Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 5: 492-500. PMID 31650005 DOI: 10.1016/J.Trci.2019.08.002  1
2019 Rocca MA, Valsasina P, Meani A, Gobbi C, Zecca C, Rovira À, Montalban X, Kearney H, Ciccarelli O, Matthews L, Palace J, Gallo A, Bisecco A, Gass A, Eisele P, ... ... Barkhof F, et al. Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS. Neurology. PMID 31611336 DOI: 10.1212/Wnl.0000000000008466  1
2019 Altomare D, de Wilde A, Ossenkoppele R, Pelkmans W, Bouwman F, Groot C, van Maurik I, Zwan M, Yaqub M, Barkhof F, van Berckel BN, Teunissen CE, Frisoni GB, Scheltens P, van der Flier WM. Applying the ATN scheme in a memory clinic population: The ABIDE project. Neurology. PMID 31597710 DOI: 10.1212/Wnl.0000000000008361  1
2019 Hupperts R, Smolders J, Vieth R, Holmøy T, Marhardt K, Schluep M, Killestein J, Barkhof F, Beelke M, Grimaldi LME. Randomized trial of daily high-dose vitamin D in patients with RRMS receiving subcutaneous interferon β-1a. Neurology. PMID 31594857 DOI: 10.1212/Wnl.0000000000008445  1
2019 de Wilde A, Ossenkoppele R, Pelkmans W, Bouwman F, Groot C, van Maurik I, Zwan M, Yaqub M, Barkhof F, Lammertsma AA, Biessels GJ, Scheltens P, van Berckel BN, van der Flier WM. Assessment of the appropriate use criteria for amyloid PET in an unselected memory clinic cohort: The ABIDE project. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31594684 DOI: 10.1016/J.Jalz.2019.07.003  1
2019 Beltrán E, Gerdes LA, Hansen J, Flierl-Hecht A, Krebs S, Blum H, Ertl-Wagner B, Barkhof F, Kümpfel T, Hohlfeld R, Dornmair K. Early adaptive immune activation detected in monozygotic twins with prodromal multiple sclerosis. The Journal of Clinical Investigation. PMID 31566584 DOI: 10.1172/Jci128475  1
2019 Eijgelaar R, De Witt Hamer PC, Peeters CFW, Barkhof F, van Herk M, Witte MG. Voxelwise statistical methods to localize practice variation in brain tumor surgery. Plos One. 14: e0222939. PMID 31560705 DOI: 10.1371/Journal.Pone.0222939  1
2019 Verburg N, Koopman T, Yaqub MM, Hoekstra OS, Lammertsma AA, Barkhof F, Pouwels PJW, Reijneveld JC, Heimans JJ, Rozemuller AJM, Bruynzeel AME, Lagerwaard F, Vandertop WP, Boellaard R, Wesseling P, et al. Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study. Neuro-Oncology. PMID 31550353 DOI: 10.1093/Neuonc/Noz180  1
2019 van Maurik IS, Vos SJ, Bos I, Bouwman FH, Teunissen CE, Scheltens P, Barkhof F, Frolich L, Kornhuber J, Wiltfang J, Maier W, Peters O, Rüther E, Nobili F, Frisoni GB, et al. Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study. The Lancet. Neurology. PMID 31526625 DOI: 10.1016/S1474-4422(19)30283-2  1
2019 Weaver NA, Doeven T, Barkhof F, Biesbroek JM, Groeneveld ON, Kuijf HJ, Prins ND, Scheltens P, Teunissen CE, van der Flier WM, Biessels GJ. Cerebral amyloid burden is associated with white matter hyperintensity location in specific posterior white matter regions. Neurobiology of Aging. PMID 31500909 DOI: 10.1016/J.Neurobiolaging.2019.08.001  1
2019 Elliott C, Belachew S, Wolinsky JS, Hauser SL, Kappos L, Barkhof F, Bernasconi C, Fecker J, Model F, Wei W, Arnold DL. Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis. Brain : a Journal of Neurology. 142: 2787-2799. PMID 31497864 DOI: 10.1093/Brain/Awz212  1
2019 Shi L, Westwood S, Baird AL, Winchester L, Dobricic V, Kilpert F, Hong S, Franke A, Hye A, Ashton NJ, Morgan AR, Bos I, Vos SJB, Buckley NJ, Kate MT, ... ... Barkhof F, et al. Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31495601 DOI: 10.1016/J.Jalz.2019.06.4951  1
2019 Eijlers AJC, Dekker I, Steenwijk MD, Meijer KA, Hulst HE, Pouwels PJW, Uitdehaag BMJ, Barkhof F, Vrenken H, Schoonheim MM, Geurts JJG. Cortical atrophy accelerates as cognitive decline worsens in multiple sclerosis. Neurology. PMID 31484713 DOI: 10.1212/Wnl.0000000000008198  1
2019 Barkhof F, Kappos L, Wolinsky JS, Li DKB, Bar-Or A, Hartung HP, Belachew S, Han J, Julian L, Sauter A, Napieralski J, Koendgen H, Hauser SL. Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis. Neurology. PMID 31484710 DOI: 10.1212/Wnl.0000000000008189  1
2019 Weeda MM, Middelkoop SM, Steenwijk MD, Daams M, Amiri H, Brouwer I, Killestein J, Uitdehaag BMJ, Dekker I, Lukas C, Bellenberg B, Barkhof F, Pouwels PJW, Vrenken H. Validation of mean upper cervical cord area (MUCCA) measurement techniques in multiple sclerosis (MS): High reproducibility and robustness to lesions, but large software and scanner effects. Neuroimage. Clinical. 24: 101962. PMID 31416017 DOI: 10.1016/J.Nicl.2019.101962  1
2019 Legdeur N, Tijms BM, Konijnenberg E, den Braber A, Ten Kate M, Sudre CH, Tomassen J, Badissi M, Yaqub M, Barkhof F, van Berckel BN, Boomsma DI, Scheltens P, Holstege H, Maier AB, et al. Associations of brain pathology, cognitive and physical markers with age in cognitively normal individuals aged 60-102 years. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 31411322 DOI: 10.1093/Gerona/Glz180  1
2019 Habets EJJ, Hendriks EJ, Taphoorn MJB, Douw L, Zwinderman AH, Vandertop WP, Barkhof F, De Witt Hamer PC, Klein M. Association between tumor location and neurocognitive functioning using tumor localization maps. Journal of Neuro-Oncology. PMID 31410731 DOI: 10.1007/S11060-019-03259-Z  1
2019 Moccia M, Prados F, Filippi M, Rocca MA, Valsasina P, Brownlee WJ, Zecca C, Gallo A, Rovira A, Gass A, Palace J, Lukas C, Vrenken H, Ourselin S, Gandini Wheeler-Kingshott CAM, ... ... Barkhof F, et al. Longitudinal spinal cord atrophy in multiple sclerosis using the generalised boundary shift integral. Annals of Neurology. PMID 31385358 DOI: 10.1002/Ana.25571  1
2019 Cotta Ramusino M, Altomare D, Bacchin R, Ingala S, Bnà C, Bonetti M, Costa A, Barkhof F, Nicolosi V, Festari C, Frisoni GB, Boccardi M. Medial temporal lobe atrophy and posterior atrophy scales normative values. Neuroimage. Clinical. 24: 101936. PMID 31382240 DOI: 10.1016/J.Nicl.2019.101936  1
2019 Dekker I, Sombekke MH, Balk LJ, Moraal B, Geurts JJ, Barkhof F, Uitdehaag BM, Killestein J, Wattjes MP. Infratentorial and spinal cord lesions: Cumulative predictors of long-term disability? Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519864933. PMID 31373535 DOI: 10.1177/1352458519864933  1
2019 Goodkin O, Pemberton H, Vos SB, Prados F, Sudre CH, Moggridge J, Cardoso MJ, Ourselin S, Bisdas S, White M, Yousry T, Thornton J, Barkhof F. The quantitative neuroradiology initiative framework: application to dementia. The British Journal of Radiology. 20190365. PMID 31368776 DOI: 10.1259/Bjr.20190365  1
2019 Archetti D, Ingala S, Venkatraghavan V, Wottschel V, Young AL, Bellio M, Bron EE, Klein S, Barkhof F, Alexander DC, Oxtoby NP, Frisoni GB, Redolfi A. Multi-study validation of data-driven disease progression models to characterize evolution of biomarkers in Alzheimer's disease. Neuroimage. Clinical. 24: 101954. PMID 31362149 DOI: 10.1016/J.Nicl.2019.101954  1
2019 Brownlee WJ, Altmann DR, Prados F, Miszkiel KA, Eshaghi A, Gandini Wheeler-Kingshott CAM, Barkhof F, Ciccarelli O. Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis. Brain : a Journal of Neurology. 142: 2276-2287. PMID 31342055 DOI: 10.1093/Brain/Awz156  1
2019 Kanber B, Nachev P, Barkhof F, Calvi A, Cardoso J, Cortese R, Prados F, Sudre CH, Tur C, Ourselin S, Ciccarelli O. Erratum: Author Correction: High-dimensional detection of imaging response to treatment in multiple sclerosis. Npj Digital Medicine. 2: 66. PMID 31341954 DOI: 10.1038/s41746-019-0144-7  1
2019 Collorone S, Prados F, Hagens MH, Tur C, Kanber B, Sudre CH, Lukas C, Gasperini C, Oreja-Guevara C, Andelova M, Ciccarelli O, Wattjes MP, Ourselin S, Altmann DR, Tijms BM, ... Barkhof F, et al. Single-subject structural cortical networks in clinically isolated syndrome. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519865739. PMID 31339446 DOI: 10.1177/1352458519865739  1
2019 Hacohen Y, Brownlee W, Mankad K, Chong WK', Thompson A, Lim M, Wassmer E, Hemingway C, Barkhof F, Ciccarelli O. Improved performance of the 2017 McDonald criteria for diagnosis of multiple sclerosis in children in a real-life cohort. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519863781. PMID 31317829 DOI: 10.1177/1352458519863781  1
2019 Kanber B, Nachev P, Barkhof F, Calvi A, Cardoso J, Cortese R, Prados F, Sudre CH, Tur C, Ourselin S, Ciccarelli O. High-dimensional detection of imaging response to treatment in multiple sclerosis. Npj Digital Medicine. 2: 49. PMID 31304395 DOI: 10.1038/s41746-019-0127-8  1
2019 Brugulat-Serrat A, Salvadó G, Sudre CH, Grau-Rivera O, Suárez-Calvet M, Falcon C, Sánchez-Benavides G, Gramunt N, Fauria K, Cardoso MJ, Barkhof F, Molinuevo JL, Gispert JD. Patterns of white matter hyperintensities associated with cognition in middle-aged cognitively healthy individuals. Brain Imaging and Behavior. PMID 31278650 DOI: 10.1007/S11682-019-00151-2  1
2019 Timmers T, Ossenkoppele R, Wolters EE, Verfaillie SCJ, Visser D, Golla SSV, Barkhof F, Scheltens P, Boellaard R, van der Flier WM, van Berckel BNM. Associations between quantitative [F]flortaucipir tau PET and atrophy across the Alzheimer's disease spectrum. Alzheimer's Research & Therapy. 11: 60. PMID 31272512 DOI: 10.1186/S13195-019-0510-3  1
2019 Altomare D, Ferrari C, Caroli A, Galluzzi S, Prestia A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall A, Carter SF, Schöll M, Choo ILH, Grimmer T, et al. Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset. Journal of Neurology. PMID 31267207 DOI: 10.1007/S00415-019-09441-7  1
2019 van Loenhoud AC, van der Flier WM, Wink AM, Dicks E, Groot C, Twisk J, Barkhof F, Scheltens P, Ossenkoppele R. Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationship. Neurology. PMID 31266904 DOI: 10.1212/Wnl.0000000000007821  1
2019 Verburg N, Koopman T, Yaqub M, Hoekstra OS, Lammertsma AA, Schwarte LA, Barkhof F, Pouwels PJW, Heimans JJ, Reijneveld JC, Rozemuller AJM, Vandertop WP, Wesseling P, Boellaard R, de Witt Hamer PC. Direct comparison of [C] choline and [F] FET PET to detect glioma infiltration: a diagnostic accuracy study in eight patients. Ejnmmi Research. 9: 57. PMID 31254208 DOI: 10.1186/S13550-019-0523-8  1
2019 Haan JD, van de Kreeke JA, Konijnenberg E, Kate MT, Braber AD, Barkhof F, van Berckel BN, Teunissen CE, Scheltens P, Visser PJ, Verbraak FD, Bouwman FH. Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 463-471. PMID 31249859 DOI: 10.1016/J.Dadm.2019.05.002  1
2019 Charidimou A, Zonneveld HI, Shams S, Kantarci K, Shoamanesh A, Hilal S, Yates PA, Boulouis G, Na HK, Pasi M, Biffi A, Chai YL, Chong JR, Wahlund LO, Clifford JR, ... ... Barkhof F, et al. and cortical superficial siderosis in CAA: Meta-analysis and potential mechanisms. Neurology. PMID 31243071 DOI: 10.1212/Wnl.0000000000007818  1
2019 Bartel F, Visser M, de Ruiter M, Belderbos J, Barkhof F, Vrenken H, de Munck JC, van Herk M. Non-linear registration improves statistical power to detect hippocampal atrophy in aging and dementia. Neuroimage. Clinical. 23: 101902. PMID 31233953 DOI: 10.1016/J.Nicl.2019.101902  1
2019 Barkhof F, Parker GJM. Reproducing Fingerprints: A Step toward Clinical Adoption. Radiology. 191146. PMID 31211635 DOI: 10.1148/Radiol.2019191146  1
2019 Filippi M, Preziosa P, Banwell BL, Barkhof F, Ciccarelli O, De Stefano N, Geurts JJG, Paul F, Reich DS, Toosy AT, Traboulsee A, Wattjes MP, Yousry TA, Gass A, Lubetzki C, et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain : a Journal of Neurology. PMID 31209474 DOI: 10.1093/Brain/Awz144  1
2019 Battaglini M, Gentile G, Luchetti L, Giorgio A, Vrenken H, Barkhof F, Cover KS, Bakshi R, Chu R, Sormani MP, Enzinger C, Ropele S, Ciccarelli O, Wheeler-Kingshott C, Yiannakas M, et al. Lifespan normative data on rates of brain volume changes. Neurobiology of Aging. 81: 30-37. PMID 31207467 DOI: 10.1016/J.Neurobiolaging.2019.05.010  1
2019 Haan JD, van de Kreeke JA, van Berckel BN, Barkhof F, Teunissen CE, Scheltens P, Verbraak FD, Bouwman FH. Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease? Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 383-391. PMID 31193094 DOI: 10.1016/J.Dadm.2019.03.006  1
2019 Mancini M, Vos SB, Vakharia VN, O'Keeffe AG, Trimmel K, Barkhof F, Dorfer C, Soman S, Winston GP, Wu C, Duncan JS, Sparks R, Ourselin S. Automated fiber tract reconstruction for surgery planning: Extensive validation in language-related white matter tracts. Neuroimage. Clinical. 23: 101883. PMID 31163386 DOI: 10.1016/J.Nicl.2019.101883  1
2019 Pelkmans W, Dicks E, Barkhof F, Vrenken H, Scheltens P, van der Flier WM, Tijms BM. Gray matter T1-w/T2-w ratios are higher in Alzheimer's disease. Human Brain Mapping. PMID 31157938 DOI: 10.1002/Hbm.24638  1
2019 Meeter LHH, Steketee RME, Salkovic D, Vos ME, Grossman M, McMillan CT, Irwin DJ, Boxer AL, Rojas JC, Olney NT, Karydas A, Miller BL, Pijnenburg YAL, Barkhof F, Sánchez-Valle R, et al. Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 31123142 DOI: 10.1136/Jnnp-2018-319784  1
2019 Frisoni GB, Alves IL, Barkhof F. IDEAS becoming reality on the roadmap for biomarker validation in Alzheimer's disease. The Lancet. Neurology. 18: 519-520. PMID 31122488 DOI: 10.1016/S1474-4422(19)30166-8  1
2019 Kim M, Snowden S, Suvitaival T, Ali A, Merkler DJ, Ahmad T, Westwood S, Baird A, Proitsi P, Nevado-Holgado A, Hye A, Bos I, Vos S, Vandenberghe R, Teunissen C, ... ... Barkhof F, et al. Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31078433 DOI: 10.1016/J.Jalz.2019.03.004  1
2019 Tur C, Grussu F, Prados F, Charalambous T, Collorone S, Kanber B, Cawley N, Altmann DR, Ourselin S, Barkhof F, Clayden JD, Toosy AT, Wheeler-Kingshott CAG, Ciccarelli O. A multi-shell multi-tissue diffusion study of brain connectivity in early multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519845105. PMID 31074686 DOI: 10.1177/1352458519845105  1
2019 Eshaghi A, Kievit RA, Prados F, Sudre CH, Nicholas J, Cardoso MJ, Chan D, Nicholas R, Ourselin S, Greenwood J, Thompson AJ, Alexander DC, Barkhof F, Chataway J, Ciccarelli O. Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. PMID 31072935 DOI: 10.1073/Pnas.1818978116  1
2019 Morgan AR, Touchard S, Leckey C, O'Hagan C, Nevado-Holgado AJ, Barkhof F, Bertram L, Blin O, Bos I, Dobricic V, Engelborghs S, Frisoni G, Frölich L, Gabel S, et al. Inflammatory biomarkers in Alzheimer's disease plasma. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31047856 DOI: 10.1016/J.Jalz.2019.03.007  1
2019 Leeuwis AE, Weaver NA, Biesbroek JM, Exalto LG, Kuijf HJ, Hooghiemstra AM, Prins ND, Scheltens P, Barkhof F, van der Flier WM, Biessels GJ. Impact of white matter hyperintensity location on depressive symptoms in memory-clinic patients: a lesion–symptom mapping study Journal of Psychiatry & Neuroscience : Jpn. 44: 1-10. PMID 31021068 DOI: 10.1503/Jpn.180136  1
2019 van Maurik IS, Slot RER, Verfaillie SCJ, Zwan MD, Bouwman FH, Prins ND, Teunissen CE, Scheltens P, Barkhof F, Wattjes MP, Molinuevo JL, Rami L, Wolfsgruber S, Peters O, Jessen F, et al. Personalized risk for clinical progression in cognitively normal subjects-the ABIDE project. Alzheimer's Research & Therapy. 11: 33. PMID 30987684 DOI: 10.1186/S13195-019-0487-Y  1
2019 Dicks E, Vermunt L, van der Flier WM, Visser PJ, Barkhof F, Scheltens P, Tijms BM. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease. Neuroimage. Clinical. 22: 101786. PMID 30921610 DOI: 10.1016/J.Nicl.2019.101786  1
2019 Boomsma JMF, Exalto LG, Barkhof F, Berg EVD, Bresser J, Heinen R, Leeuwis AE, Prins ND, Scheltens P, Weinstein HC, van der Flier WM, Biessels GJ. How Do Different Forms of Vascular Brain Injury Relate to Cognition in a Memory Clinic Population: The TRACE-VCI Study. Journal of Alzheimer's Disease : Jad. PMID 30909212 DOI: 10.3233/Jad-180696  1
2019 Kuijf HJ, Biesbroek JM, de Bresser J, Heinen R, Andermatt S, Bento M, Berseth M, Belyaev M, Cardoso MJ, Casamitjana A, Collins DL, Dadar M, Georgiou A, Ghafoorian M, Jin D, ... ... Barkhof F, et al. Standardized Assessment of Automatic Segmentation of White Matter Hyperintensities; Results of the WMH Segmentation Challenge. Ieee Transactions On Medical Imaging. PMID 30908194 DOI: 10.1109/Tmi.2019.2905770  1
2019 d'Ambrosio A, Valsasina P, Gallo A, De Stefano N, Pareto D, Barkhof F, Ciccarelli O, Enzinger C, Tedeschi G, Stromillo ML, Arévalo MJ, Hulst HE, Muhlert N, Koini M, Filippi M, et al. Reduced dynamics of functional connectivity and cognitive impairment in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519837707. PMID 30887862 DOI: 10.1177/1352458519837707  1
2019 Smith LA, Melbourne A, Owen D, Cardoso MJ, Sudre CH, Tillin T, Sokolska M, Atkinson D, Chaturvedi N, Ourselin S, Hughes AD, Barkhof F, Jäger HR. Cortical cerebral blood flow in ageing: effects of haematocrit, sex, ethnicity and diabetes. European Radiology. PMID 30887200 DOI: 10.1007/s00330-019-06096-w  1
2019 Bos I, Vos S, Verhey F, Scheltens P, Teunissen C, Engelborghs S, Sleegers K, Frisoni G, Blin O, Richardson JC, Bordet R, Tsolaki M, Popp J, Peyratout G, Martinez-Lage P, ... ... Barkhof F, et al. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30853464 DOI: 10.1016/J.Jalz.2019.01.004  1
2019 Vernooij MW, Pizzini FB, Schmidt R, Smits M, Yousry TA, Bargallo N, Frisoni GB, Haller S, Barkhof F. Dementia imaging in clinical practice: a European-wide survey of 193 centres and conclusions by the ESNR working group. Neuroradiology. PMID 30852630 DOI: 10.1007/S00234-019-02188-Y  1
2019 Ferro DA, van den Brink H, Exalto LG, Boomsma JMF, Barkhof F, Prins ND, van der Flier WM, Biessels GJ. Clinical relevance of acute cerebral microinfarcts in vascular cognitive impairment. Neurology. PMID 30850444 DOI: 10.1212/Wnl.0000000000007250  1
2019 Visser M, Müller DMJ, van Duijn RJM, Smits M, Verburg N, Hendriks EJ, Nabuurs RJA, Bot JCJ, Eijgelaar RS, Witte M, van Herk MB, Barkhof F, de Witt Hamer PC, de Munck JC. Inter-rater agreement in glioma segmentations on longitudinal MRI. Neuroimage. Clinical. 22: 101727. PMID 30825711 DOI: 10.1016/J.Nicl.2019.101727  1
2019 Koikkalainen JR, Rhodius-Meester HFM, Frederiksen KS, Bruun M, Hasselbalch SG, Baroni M, Mecocci P, Vanninen R, Remes A, Soininen H, van Gils M, van der Flier WM, Scheltens P, Barkhof F, Erkinjuntti T, et al. Automatically computed rating scales from MRI for patients with cognitive disorders. European Radiology. PMID 30796570 DOI: 10.1007/S00330-019-06067-1  1
2019 Groeneveld ON, Moneti C, Heinen R, de Bresser J, Kuijf HJ, Exalto LG, Boomsma JMF, Kappelle LJ, Barkhof F, Prins ND, Scheltens P, van der Flier WM, Biessels GJ. The Clinical Phenotype of Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus. Journal of Alzheimer's Disease : Jad. PMID 30775988 DOI: 10.3233/Jad-180914  1
2019 Liu Y, Dong D, Zhang L, Zang Y, Duan Y, Qiu X, Huang J, Dong H, Barkhof F, Hu C, Fang M, Tian J, Li K. Radiomics in multiple sclerosis and neuromyelitis optica spectrum disorder. European Radiology. PMID 30770971 DOI: 10.1007/S00330-019-06026-W  1
2019 Bruun M, Koikkalainen J, Rhodius-Meester HFM, Baroni M, Gjerum L, van Gils M, Soininen H, Remes AM, Hartikainen P, Waldemar G, Mecocci P, Barkhof F, Pijnenburg Y, van der Flier WM, Hasselbalch SG, et al. Detecting frontotemporal dementia syndromes using MRI biomarkers. Neuroimage. Clinical. 22: 101711. PMID 30743135 DOI: 10.1016/J.Nicl.2019.101711  1
2019 Jonkman LE, Graaf YG, Bulk M, Kaaij E, Pouwels PJW, Barkhof F, Rozemuller AJM, van der Weerd L, Geurts JJG, van de Berg WDJ. Normal Aging Brain Collection Amsterdam (NABCA): A comprehensive collection of postmortem high-field imaging, neuropathological and morphometric datasets of non-neurological controls. Neuroimage. Clinical. 22: 101698. PMID 30711684 DOI: 10.1016/J.Nicl.2019.101698  1
2019 Salvadó G, Brugulat-Serrat A, Sudre CH, Grau-Rivera O, Suárez-Calvet M, Falcon C, Fauria K, Cardoso MJ, Barkhof F, Molinuevo JL, Gispert JD. Spatial patterns of white matter hyperintensities associated with Alzheimer's disease risk factors in a cognitively healthy middle-aged cohort. Alzheimer's Research & Therapy. 11: 12. PMID 30678723 DOI: 10.1186/S13195-018-0460-1  1
2019 Müller DMJ, Robe PAJT, Eijgelaar RS, Witte MG, Visser M, de Munck JC, Broekman MLD, Seute T, Hendrikse J, Noske DP, Vandertop WP, Barkhof F, Kouwenhoven MCM, Mandonnet E, Berger MS, et al. Comparing Glioblastoma Surgery Decisions Between Teams Using Brain Maps of Tumor Locations, Biopsies, and Resections. Jco Clinical Cancer Informatics. 1-12. PMID 30673344 DOI: 10.1200/CCI.18.00089  1
2019 Amiri H, Brouwer I, Kuijer JPA, de Munck JC, Barkhof F, Vrenken H. Novel imaging phantom for accurate and robust measurement of brain atrophy rates using clinical MRI. Neuroimage. Clinical. 21: 101667. PMID 30665101 DOI: 10.1016/J.Nicl.2019.101667  1
2019 Emanuel AL, van Duinkerken E, Wattjes MP, Klein M, Barkhof F, Snoek FJ, Diamant M, Eringa EC, IJzerman RG, Serné EH. The presence of cerebral white matter lesions and lower skin microvascular perfusion predict lower cognitive performance in type 1 diabetes patients with retinopathy but not in healthy controls - a longitudinal study. Microcirculation (New York, N.Y. : 1994). e12530. PMID 30659710 DOI: 10.1111/Micc.12530  1
2019 Oudega ML, van der Werf YD, Dols A, Wattjes MP, Barkhof F, Bouckaert F, Vandenbulcke M, De Winter FL, Sienaert P, Eikelenboom P, Stek ML, van den Heuvel OA, Emsell L, Rhebergen D, van Exel E. Exploring resting state connectivity in patients with psychotic depression. Plos One. 14: e0209908. PMID 30653516 DOI: 10.1371/Journal.Pone.0209908  1
2019 Dekker I, Eijlers AJC, Popescu V, Balk LJ, Vrenken H, Wattjes MP, Uitdehaag BMJ, Killestein J, Geurts JJG, Barkhof F, Schoonheim MM. Predicting clinical progression in multiple sclerosis after 6 and 12 years. European Journal of Neurology. PMID 30629788 DOI: 10.1111/Ene.13904  1
2019 Garbarino S, Lorenzi M, Oxtoby NP, Vinke EJ, Marinescu RV, Eshaghi A, Ikram MA, Niessen WJ, Ciccarelli O, Barkhof F, Schott JM, Vernooij MW, Alexander DC. Author response: Differences in topological progression profile among neurodegenerative diseases from imaging data Elife. DOI: 10.7554/Elife.49298.Sa2  1
2019 Hönig MC, Bischof GN, Alves IL, Ahlswede M, Sakagiannis P, Jessen F, Schmidt ME, Barkhof F, Eimeren Tv, Drzezga A. P1‐350: Hippocampal Intrinsic Connectivity Supports Cognitive Reserve In Amyloid‐Positive Cognitively Normal Subjects And Alzheimer'S Disease Patients Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.905  1
2019 Lötjönen J, Koikkalainen J, Meester HFMR, Baroni M, Mecocci P, Remes A, Soininen H, Erkinjuntti T, Teunissen CE, Scheltens P, Barkhof F, Flier WMvd, Law I, Hasselbalch SG, Frederiksen KS. P1‐347: Detecting Alzheimer'S Disease At Different Levels Of White‐Matter Hyperintensities Using Mri Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.902  1
2019 Singleton EH, Pijnenburg YAL, Sudre CH, Kochova E, Groot C, Papma JM, Swieten JCv, Barkhof F, Scheltens P, Rabinovici GD, Ossenkoppele R. Ic-P-097: Differentiating The Behavioural Variant Of Alzheimer'S Disease From Behavioural Variant Frontotemporal Dementia And Typical Alzheimer'S Disease: The Value Of Neuroimaging Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4940  1
2019 Bos I, Vos SJB, Kate Mt, Jansen WJ, Scheltens P, Engelborghs S, Frisoni GB, Blin O, Richardson J, Bordet R, Tsolaki M, Verhey FRJ, Popp J, Martinez-Lage P, Vandenberghe R, ... ... Barkhof F, et al. Associations Between Cerebrospinal Fluid Neurodegenerative Markers, Neurofilament-Light And Total Tau And Cerebrovascular Imaging Markers Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4860  1
2019 Loenhoud ACv, Groot C, Barkhof F, Scheltens P, Flier WMvd, Ossenkoppele R. Ic-P-100: A Longitudinal Study Of The Effects Of Education And Intracranial Volume On Cognitive Changes And Mortality Rates In Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4766  1
2019 Leijenaar JF, Groot C, Sudre CH, Bergeron D, Leeuwis AE, Cardoso J, Carrasco FP, Laforce R, Barkhof F, Flier WMvd, Scheltens P, Prins ND, Ossenkoppele R. COMORBID AMYLOID-β PATHOLOGY AFFECTS NEUROPSYCHIATRIC, NEUROPSYCHOLOGICAL, AND IMAGING FEATURES IN VASCULAR COGNITIVE DISORDERS Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4647  1
2019 Salvadó G, Ferreira D, Cacciaglia R, Operto G, Falcon C, Groot C, Flier WMvd, Barkhof F, Scheltens P, Ossenkoppele R, Stomrud E, Westen Dv, Hansson O, Molinuevo JL, Wahlund L, et al. O3-02-06: COGNITIVELY NORMAL APOE-ε2 HOMOZYGOTES DISPLAY GREATER HIPPOCAMPI: AN UNBIASED VOXEL-BASED ANALYSIS Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4635  1
2019 Meester HFR, Maurik ISV, Koikkalainen J, Barkhof F, Teunissen CE, Frederiksen KS, Scheltens P, Meccocci P, Baroni M, Remes A, Soininen H, Hasselbalch SG, Flier WMvd, Lötjönen J. O2-02-03: Stepwise Patient Selection For Amyloid Measurements Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4459  1
2019 Ebenau J, Timmers T, Wesselman LMP, Verberk IMW, Verfaillie SCJ, Slot RER, Teunissen CE, Barkhof F, Bosch Kvd, Leeuwenstijn Mv, Prins ND, Sikkes SAM, Scheltens P, Berckel BNMV, Flier WMvd. Atn Biomarker Model As A Determinant Of Cognitive Decline And Incident Clinical Progression In Subjective Cognitive Decline: The Science Project Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4383  1
2019 Alves IL, Doull L, Gunn F, Farrar G, Barkhof F, Ford L, Ritchie CW. P4-307: The Added Value Of Quantitative Amyloid Pet In Determining Alzheimer'S Disease (Ad) Dementia Risk: The Amypad Prognostic And Natural History Study Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3977  1
2019 Altomare D, Barkhof F, Berkhof J, Boccardi M, Canzoneri E, Collij L, Drzezga A, Farrar G, Garibotto V, Gismondi R, Gispert JD, Jessen F, Kivipelto M, Alves IL, Molinuevo JL, et al. P3-373: Amypad-Dpms Preliminary Results: Participants’ Baseline Features Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3406  1
2019 Brugulat-Serrat A, Salvadó G, Operto G, Cacciaglia R, Sudre CH, Grau-Rivera O, Suárez-Calvet M, Falcon C, Sánchez-Benavides G, Gramunt N, Minguillon C, Fauria K, Barkhof F, Molinuevo JL, Gispert JD, et al. P3-323: White Matter Hyperintensities Mediate The Relationship Between Gray Matter Volume And Executive Function In Cognitively Unimpaired Middle-Aged Individuals Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3355  1
2019 Leeuwis AE, Hooghiemstra AM, Bron EE, Kuipers S, Oudeman EA, Kalay T, Rocca HHPB, Kappelle J, Oostenbrugge RJv, Greving JP, Niessen WJ, Buchem MAv, Osch MJPv, Rossum Av, Prins ND, ... ... Barkhof F, et al. Cognitive Functioning In Patients With Disorders Along The Heart-Brain Axis: The Role Of Cerebral Blood Flow Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2799  1
2019 Legdeur N, Badissi M, Yaqub MM, Beker N, Sudre CH, Kate Mt, Gordon MF, Novak GP, Barkhof F, Berckel BNMV, Holstege H, Muller M, Scheltens P, Maier AB, Visser PJ. P2-345: What Determines Cognitive Functioning In The Oldest-Old? The Emif-Ad 90+ Study Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2752  1
2019 Briels CT, Scheltens NME, Yaqub MM, Barkhof F, Boellaard R, Flier WMvd, Schwarte LA, Teunissen CE, Broersen LM, Berckel BNMV, Scheltens P. P2-016: Exploring The Effect Of Souvenaid On Cerebral Glucose Metabolism In Early Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.1238  1
2019 Salvadó G, Collij L, Niñerola-Baizán A, Perissinotti A, Flier WMvd, Visser PJ, Scheltens P, Zetterberg H, Blennow K, Barkhof F, Molinuevo JL, Alves IL, Gispert JD, Study A, Adni. Ic-P-015: Voxel-Based Amyloid Pet Staging For The Whole Alzheimer'S Disease Continuum Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.1026  1
2018 Rhodius-Meester HFM, Liedes H, Koikkalainen J, Wolfsgruber S, Coll-Padros N, Kornhuber J, Peters O, Jessen F, Kleineidam L, Molinuevo JL, Rami L, Teunissen CE, Barkhof F, Sikkes SAM, Wesselman LMP, et al. Computer-assisted prediction of clinical progression in the earliest stages of AD. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 726-736. PMID 30619929 DOI: 10.1016/J.Dadm.2018.09.001  1
2018 Gasperini C, Prosperini L, Tintoré M, Sormani MP, Filippi M, Rio J, Palace J, Rocca MA, Ciccarelli O, Barkhof F, Sastre-Garriga J, Vrenken H, Frederiksen JL, Yousry TA, Enzinger C, et al. Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge. Neurology. PMID 30587516 DOI: 10.1212/Wnl.0000000000006810  1
2018 Elliott C, Wolinsky JS, Hauser SL, Kappos L, Barkhof F, Bernasconi C, Wei W, Belachew S, Arnold DL. Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518814117. PMID 30566027 DOI: 10.1177/1352458518814117  1
2018 Jutten RJ, Dicks E, Vermaat L, Barkhof F, Scheltens P, Tijms BM, Sikkes SAM. Impairment in complex activities of daily living is related to neurodegeneration in Alzheimer's disease-specific regions. Neurobiology of Aging. 75: 109-116. PMID 30557769 DOI: 10.1016/J.Neurobiolaging.2018.11.018  1
2018 Legdeur N, Badissi M, Carter SF, de Crom S, van de Kreeke A, Vreeswijk R, Trappenburg MC, Oudega ML, Koek HL, van Campen JP, Keijsers CJPW, Amadi C, Hinz R, Gordon MF, Novak G, ... ... Barkhof F, et al. Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study. Bmc Geriatrics. 18: 289. PMID 30477432 DOI: 10.1186/S12877-018-0984-Z  1
2018 Hagens MHJ, Golla SV, Wijburg MT, Yaqub M, Heijtel D, Steenwijk MD, Schober P, Brevé JJP, Schuit RC, Reekie TA, Kassiou M, van Dam AM, Windhorst AD, Killestein J, Barkhof F, et al. In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [F]DPA714 PET. Journal of Neuroinflammation. 15: 314. PMID 30424780 DOI: 10.1186/S12974-018-1352-9  1
2018 Hendriks EJ, Idema S, Hervey-Jumper SL, Bernat AL, Zwinderman AH, Barkhof F, Vandertop WP, Mandonnet E, Duffau H, Berger MS, De Witt Hamer PC. Preoperative Resectability Estimates of Nonenhancing Glioma by Neurosurgeons and a Resection Probability Map. Neurosurgery. PMID 30423155 DOI: 10.1093/Neuros/Nyy487  1
2018 Ten Kate M, Ingala S, Schwarz AJ, Fox NC, Chételat G, van Berckel BNM, Ewers M, Foley C, Gispert JD, Hill D, Irizarry MC, Lammertsma AA, Molinuevo JL, Ritchie C, Scheltens P, ... ... Barkhof F, et al. Secondary prevention of Alzheimer's dementia: neuroimaging contributions. Alzheimer's Research & Therapy. 10: 112. PMID 30376881 DOI: 10.1186/S13195-018-0438-Z  1
2018 Sudre CH, Smith L, Atkinson D, Chaturvedi N, Ourselin S, Barkhof F, Hughes AD, Jäger HR, Cardoso MJ. Cardiovascular Risk Factors and White Matter Hyperintensities: Difference in Susceptibility in South Asians Compared With Europeans. Journal of the American Heart Association. 7: e010533. PMID 30376748 DOI: 10.1161/Jaha.118.010533  1
2018 Ten Kate M, Dicks E, Visser PJ, van der Flier WM, Teunissen CE, Barkhof F, Scheltens P, Tijms BM. Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline. Brain : a Journal of Neurology. PMID 30351346 DOI: 10.1093/Brain/Awy264  1
2018 Groot C, Sudre CH, Barkhof F, Teunissen CE, van Berckel BNM, Seo SW, Ourselin S, Scheltens P, Cardoso MJ, van der Flier WM, Ossenkoppele R. Clinical phenotype, atrophy, and small vessel disease in ε2 carriers with Alzheimer disease. Neurology. PMID 30341156 DOI: 10.1212/Wnl.0000000000006503  1
2018 Frisoni GB, Barkhof F, Altomare D, Berkhof J, Boccardi M, Canzoneri E, Collij L, Drzezga A, Farrar G, Garibotto V, Gismondi R, Gispert JD, Jessen F, Kivipelto M, Alves IL, et al. AMYPAD Diagnostic and Patient Management Study: Rationale and design. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30339801 DOI: 10.1016/J.Jalz.2018.09.003  1
2018 van de Kreeke JA, Nguyen HT, Konijnenberg E, Tomassen J, den Braber A, Ten Kate M, Sudre CH, Barkhof F, Boomsma DI, Tan HS, Verbraak FD, Visser PJ. Retinal and Cerebral Microvasculopathy: Relationships and Their Genetic Contributions. Investigative Ophthalmology & Visual Science. 59: 5025-5031. PMID 30326071 DOI: 10.1167/Iovs.18-25341  1
2018 Hu X, Teunissen C, Spottke A, Heneka MT, Düzel E, Peters O, Li S, Priller J, Bürger K, Teipel S, Laske C, Verfaillie S, Barkhof F, Coll-Padrós N, Rami L, et al. Smaller medial temporal lobe volumes in individuals with subjective cognitive decline and biomarker evidence of Alzheimer's disease-Data from three memory clinic studies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30321506 DOI: 10.1016/J.Jalz.2018.09.002  1
2018 Bruun M, Rhodius-Meester HFM, Koikkalainen J, Baroni M, Gjerum L, Lemstra AW, Barkhof F, Remes AM, Urhemaa T, Tolonen A, Rueckert D, van Gils M, Frederiksen KS, Waldemar G, Scheltens P, et al. Evaluating combinations of diagnostic tests to discriminate different dementia types. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 509-518. PMID 30320203 DOI: 10.1016/J.Dadm.2018.07.003  1
2018 Collij L, Konijnenberg E, Reimand J, Ten Kate M, Den Braber A, Lopes Alves I, Zwan M, Yaqub M, Van Assema D, Wink AM, Lammertsma A, Scheltens P, Visser PJ, Barkhof F, Van Berckel B. Assessing Amyloid Pathology in Cognitively Normal Subjects using [F]Flutemetamol PET: Comparing Visual Reads and Quantitative Methods. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30315145 DOI: 10.2967/Jnumed.118.211532  1
2018 Leeuwis AE, Smith LA, Melbourne A, Hughes AD, Richards M, Prins ND, Sokolska M, Atkinson D, Tillin T, Jäger HR, Chaturvedi N, van der Flier WM, Barkhof F. Cerebral Blood Flow and Cognitive Functioning in a Community-Based, Multi-Ethnic Cohort: The SABRE Study. Frontiers in Aging Neuroscience. 10: 279. PMID 30279656 DOI: 10.3389/Fnagi.2018.00279  1
2018 Rocca MA, Barkhof F, De Luca J, Frisén J, Geurts JJG, Hulst HE, Sastre-Garriga J, Filippi M. The hippocampus in multiple sclerosis. The Lancet. Neurology. 17: 918-926. PMID 30264730 DOI: 10.1016/S1474-4422(18)30309-0  1
2018 Ten Kate M, Redolfi A, Peira E, Bos I, Vos SJ, Vandenberghe R, Gabel S, Schaeverbeke J, Scheltens P, Blin O, Richardson JC, Bordet R, Wallin A, Eckerstrom C, Molinuevo JL, ... ... Barkhof F, et al. MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study. Alzheimer's Research & Therapy. 10: 100. PMID 30261928 DOI: 10.1186/S13195-018-0428-1  1
2018 Ostrowitzki S, Lasser RA, Dorflinger E, Scheltens P, Barkhof F, Nikolcheva T, Ashford E, Retout S, Hofmann C, Delmar P, Klein G, Andjelkovic M, Dubois B, Boada M, Blennow K, et al. Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease. Alzheimer's Research & Therapy. 10: 99. PMID 30261916 DOI: 10.1186/S13195-018-0409-4  1
2018 Eijlers AJC, van Geest Q, Dekker I, Steenwijk MD, Meijer KA, Hulst HE, Barkhof F, Uitdehaag BMJ, Schoonheim MM, Geurts JJG. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study. Brain : a Journal of Neurology. 141: 2605-2618. PMID 30169585 DOI: 10.1093/Brain/Awy202  1
2018 Connick P, De Angelis F, Parker RA, Plantone D, Doshi A, John N, Stutters J, MacManus D, Prados Carrasco F, Barkhof F, Ourselin S, Braisher M, Ross M, Cranswick G, Pavitt SH, et al. Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis. Bmj Open. 8: e021944. PMID 30166303 DOI: 10.1136/Bmjopen-2018-021944  1
2018 Bendfeldt K, Taschler B, Gaetano L, Madoerin P, Kuster P, Mueller-Lenke N, Amann M, Vrenken H, Wottschel V, Barkhof F, Borgwardt S, Klöppel S, Wicklein EM, Kappos L, Edan G, et al. MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry. Brain Imaging and Behavior. PMID 30155789 DOI: 10.1007/S11682-018-9942-9  1
2018 Wink AM, Tijms BM, Ten Kate M, Raspor E, de Munck JC, Altena E, Ecay-Torres M, Clerigue M, Estanga A, Garcia-Sebastian M, Izagirre A, Martinez-Lage Alvarez P, Villanua J, Barkhof F, Sanz-Arigita E. Functional brain network centrality is related to APOE genotype in cognitively normal elderly. Brain and Behavior. e01080. PMID 30136422 DOI: 10.1002/Brb3.1080  1
2018 Brownlee WJ, Miszkiel KA, Tur C, Barkhof F, Miller DH, Ciccarelli O. Inclusion of optic nerve involvement in dissemination in space criteria for multiple sclerosis. Neurology. PMID 30120132 DOI: 10.1212/Wnl.0000000000006207  1
2018 Wolters EE, Golla SSV, Timmers T, Ossenkoppele R, van der Weijden CWJ, Scheltens P, Schwarte L, Schuit RC, Windhorst AD, Barkhof F, Yaqub M, Lammertsma AA, Boellaard R, van Berckel BNM. A novel partial volume correction method for accurate quantification of [F] flortaucipir in the hippocampus. Ejnmmi Research. 8: 79. PMID 30112620 DOI: 10.1186/S13550-018-0432-2  1
2018 Reus LM, Vijverberg EG, Tijms BM, Kate MT, Gossink F, Krudop WA, Campo MD, Teunissen CE, Barkhof F, van der Flier WM, Visser PJ, Dols A, Pijnenburg YA. Disease trajectories in behavioural variant frontotemporal dementia, primary psychiatric and other neurodegenerative disorders presenting with behavioural change. Journal of Psychiatric Research. 104: 183-191. PMID 30103065 DOI: 10.1016/J.Jpsychires.2018.07.014  1
2018 Wijburg MT, Warnke C, Barkhof F, Uitdehaag BMJ, Killestein J, Wattjes MP. Performance of PML diagnostic criteria in natalizumab-associated PML: data from the Dutch-Belgian cohort. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 30100552 DOI: 10.1136/Jnnp-2018-318261  1
2018 Slot RER, Verfaillie SCJ, Overbeek JM, Timmers T, Wesselman LMP, Teunissen CE, Dols A, Bouwman FH, Prins ND, Barkhof F, Lammertsma AA, Van Berckel BNM, Scheltens P, Sikkes SAM, Van der Flier WM. Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results. Alzheimer's Research & Therapy. 10: 76. PMID 30081935 DOI: 10.1186/S13195-018-0390-Y  1
2018 Konijnenberg E, Carter SF, Ten Kate M, den Braber A, Tomassen J, Amadi C, Wesselman L, Nguyen HT, van de Kreeke JA, Yaqub M, Demuru M, Mulder SD, Hillebrand A, Bouwman FH, Teunissen CE, ... ... Barkhof F, et al. The EMIF-AD PreclinAD study: study design and baseline cohort overview. Alzheimer's Research & Therapy. 10: 75. PMID 30075734 DOI: 10.1186/S13195-018-0406-7  1
2018 de Wilde A, van Buchem MM, Otten RHJ, Bouwman F, Stephens A, Barkhof F, Scheltens P, van der Flier WM. Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic review. Alzheimer's Research & Therapy. 10: 72. PMID 30055660 DOI: 10.1186/S13195-018-0398-3  1
2018 Groot C, Tolboom N, Ikonomovic MD, Lammertsma AA, Boon BDC, Barkhof F, Scheltens P, Klunk WE, Rozemuller AJM, Ossenkoppele R, van Berckel BNM. Quantitative PET and Histology of Brain Biopsy Reveal Lack of Selective Pittsburgh Compound-B Binding to Intracerebral Amyloidoma. Journal of Alzheimer's Disease : Jad. PMID 30040724 DOI: 10.3233/Jad-180316  1
2018 Shu N, Duan Y, Huang J, Ren Z, Liu Z, Dong H, Barkhof F, Li K, Liu Y. Progressive brain rich-club network disruption from clinically isolated syndrome towards multiple sclerosis. Neuroimage. Clinical. 19: 232-239. PMID 30035017 DOI: 10.1016/J.Nicl.2018.03.034  1
2018 Barkhof F, Thomas DL. Mapping Deep Gray Matter Iron in Multiple Sclerosis by Using Quantitative Magnetic Susceptibility. Radiology. 181274. PMID 30015585 DOI: 10.1148/Radiol.2018181274  1
2018 Scheltens NME, van der Weijden K, Adriaanse SM, van Assema D, Oomen PP, Krudop WA, Lammertsma AA, Barkhof F, Koene T, Teunissen CE, Scheltens P, van der Flier WM, Pijnenburg YAL, Yaqub M, Ossenkoppele R, et al. Hypometabolism of the posterior cingulate cortex is not restricted to Alzheimer's disease. Neuroimage. Clinical. 19: 625-632. PMID 29984170 DOI: 10.1016/J.Nicl.2018.05.024  1
2018 Amiri H, de Sitter A, Bendfeldt K, Battaglini M, Gandini Wheeler-Kingshott CAM, Calabrese M, Geurts JJG, Rocca MA, Sastre-Garriga J, Enzinger C, de Stefano N, Filippi M, Rovira Á, Barkhof F, Vrenken H, et al. Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI. Neuroimage. Clinical. 19: 466-475. PMID 29984155 DOI: 10.1016/J.Nicl.2018.04.023  1
2018 Bos I, Vos S, Vandenberghe R, Scheltens P, Engelborghs S, Frisoni G, Molinuevo JL, Wallin A, Lleó A, Popp J, Martinez-Lage P, Baird A, Dobson R, Legido-Quigley C, Sleegers K, ... ... Barkhof F, et al. The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics. Alzheimer's Research & Therapy. 10: 64. PMID 29980228 DOI: 10.1186/S13195-018-0396-5  1
2018 Prados F, Barkhof F. Spinal cord atrophy rates: Ready for prime time in multiple sclerosis clinical trials? Neurology. PMID 29950433 DOI: 10.1212/Wnl.0000000000005873  1
2018 Hagens MHJ, Burggraaff J, Kilsdonk ID, de Vos ML, Cawley N, Sbardella E, Andelova M, Amann M, Lieb JM, Pantano P, Lissenberg-Witte BI, Killestein J, Oreja-Guevara C, Ciccarelli O, Gasperini C, ... ... Barkhof F, et al. Three-Tesla MRI does not improve the diagnosis of multiple sclerosis: A multicenter study. Neurology. PMID 29925550 DOI: 10.1212/Wnl.0000000000005825  1
2018 Tolonen A, Rhodius-Meester HFM, Bruun M, Koikkalainen J, Barkhof F, Lemstra AW, Koene T, Scheltens P, Teunissen CE, Tong T, Guerrero R, Schuh A, Ledig C, Baroni M, Rueckert D, et al. Data-Driven Differential Diagnosis of Dementia Using Multiclass Disease State Index Classifier. Frontiers in Aging Neuroscience. 10: 111. PMID 29922145 DOI: 10.3389/Fnagi.2018.00111  1
2018 de Wilde A, van der Flier WM, Pelkmans W, Bouwman F, Verwer J, Groot C, van Buchem MM, Zwan M, Ossenkoppele R, Yaqub M, Kunneman M, Smets EMA, Barkhof F, Lammertsma AA, Stephens A, et al. Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort: The ABIDE Project. Jama Neurology. PMID 29889941 DOI: 10.1001/Jamaneurol.2018.1346  1
2018 Leeuwis AE, Prins ND, Hooghiemstra AM, Benedictus MR, Scheltens P, Barkhof F, van der Flier WM. Microbleeds are associated with depressive symptoms in Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 112-120. PMID 29780860 DOI: 10.1016/J.Dadm.2017.11.006  1
2018 Eijgelaar RS, Bruynzeel AME, Lagerwaard FJ, Müller DMJ, Teunissen FR, Barkhof F, van Herk M, De Witt Hamer PC, Witte MG. Earliest radiological progression in glioblastoma by multidisciplinary consensus review. Journal of Neuro-Oncology. PMID 29777418 DOI: 10.1007/S11060-018-2896-3  1
2018 Eshaghi A, Marinescu RV, Young AL, Firth NC, Prados F, Jorge Cardoso M, Tur C, De Angelis F, Cawley N, Brownlee WJ, De Stefano N, Laura Stromillo M, Battaglini M, Ruggieri S, Gasperini C, ... ... Barkhof F, et al. Progression of regional grey matter atrophy in multiple sclerosis. Brain : a Journal of Neurology. PMID 29741648 DOI: 10.1093/Brain/Awy088  1
2018 Haller S, Barkhof F. Peri-hippocampal developmental venous anomalies and memory loss: more than a normal variant? Neuroradiology. PMID 29700565 DOI: 10.1007/S00234-018-2026-0  1
2018 Liu Y, Duan Y, Dong H, Barkhof F, Li K, Shu N. Disrupted Module Efficiency of Structural and Functional Brain Connectomes in Clinically Isolated Syndrome and Multiple Sclerosis. Frontiers in Human Neuroscience. 12: 138. PMID 29692717 DOI: 10.3389/Fnhum.2018.00138  1
2018 van Duinkerken E, Steenwijk MD, Klein M, Barkhof F, Mograbi DC, Diamant M, Snoek FJ, Ijzerman RG. Accelerated executive functions decline and gray matter structural changes in middle-aged type 1 diabetes patients with proliferative retinopathy. Journal of Diabetes. PMID 29665283 DOI: 10.1111/1753-0407.12773  1
2018 Bernardes G, IJzerman RG, Ten Kulve JS, Barkhof F, Diamant M, Veltman DJ, Landeira-Fernandez J, van Bloemendaal L, van Duinkerken E. Cortical and subcortical gray matter structural alterations in normoglycemic obese and type 2 diabetes patients: relationship with adiposity, glucose, and insulin. Metabolic Brain Disease. PMID 29654499 DOI: 10.1007/S11011-018-0223-5  1
2018 Bouts MJRJ, Möller C, Hafkemeijer A, van Swieten JC, Dopper E, van der Flier WM, Vrenken H, Wink AM, Pijnenburg YAL, Scheltens P, Barkhof F, Schouten TM, de Vos F, Feis RA, van der Grond J, et al. Single Subject Classification of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Anatomical, Diffusion Tensor, and Resting-State Functional Magnetic Resonance Imaging. Journal of Alzheimer's Disease : Jad. PMID 29614652 DOI: 10.3233/Jad-170893  1
2018 Verfaillie SCJ, Slot RER, Dicks E, Prins ND, Overbeek JM, Teunissen CE, Scheltens P, Barkhof F, van der Flier WM, Tijms BM. A more randomly organized grey matter network is associated with deteriorating language and global cognition in individuals with subjective cognitive decline. Human Brain Mapping. PMID 29602212 DOI: 10.1002/Hbm.24065  1
2018 Ten Kate M, Visser PJ, Bakardjian H, Barkhof F, Sikkes SAM, van der Flier WM, Scheltens P, Hampel H, Habert MO, Dubois B, Tijms BM. Gray Matter Network Disruptions and Regional Amyloid Beta in Cognitively Normal Adults. Frontiers in Aging Neuroscience. 10: 67. PMID 29599717 DOI: 10.3389/Fnagi.2018.00067  1
2018 Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, et al. The current role of MRI in differentiating multiple sclerosis from its imaging mimics. Nature Reviews. Neurology. 14: 213. PMID 29582852 DOI: 10.1038/nrneurol.2018.39  1
2018 Leijenaar JF, Groeneveld GJ, van der Flier WM, Scheltens P, Klaassen ES, Weinstein HC, Biessels GJ, Barkhof F, Prins ND. Symptomatic Treatment of Vascular Cognitive Impairment (STREAM-VCI): Protocol for a Cross-Over Trial. Jmir Research Protocols. 7: e80. PMID 29559423 DOI: 10.2196/Resprot.9192  1
2018 Haller S, Vernooij MW, Kuijer JPA, Larsson EM, Jäger HR, Barkhof F. Cerebral Microbleeds: Imaging and Clinical Significance. Radiology. 287: 11-28. PMID 29558307 DOI: 10.1148/Radiol.2018170803  1
2018 Wijburg MT, Kleerekooper I, Lissenberg-Witte BI, de Vos M, Warnke C, Uitdehaag BMJ, Barkhof F, Killestein J, Wattjes MP. Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis. Jama Neurology. PMID 29532061 DOI: 10.1001/Jamaneurol.2018.0094  1
2018 Buck D, Andlauer TF, Igl W, Wicklein EM, Mühlau M, Weber F, Köchert K, Pohl C, Arnason B, Comi G, Cook S, Filippi M, Hartung HP, Jeffery D, Kappos L, ... Barkhof F, et al. Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518763089. PMID 29521573 DOI: 10.1177/1352458518763089  1
2018 Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, et al. The current role of MRI in differentiating multiple sclerosis from its imaging mimics. Nature Reviews. Neurology. PMID 29521337 DOI: 10.1038/Nrneurol.2018.14  1
2018 Cortese R, Magnollay L, Tur C, Abdel-Aziz K, Jacob A, De Angelis F, Yiannakas MC, Prados F, Ourselin S, Yousry TA, Barkhof F, Ciccarelli O. Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD. Neurology. PMID 29514948 DOI: 10.1212/Wnl.0000000000005256  1
2018 Ten Kate M, Sudre CH, den Braber A, Konijnenberg E, Nivard MG, Cardoso MJ, Scheltens P, Ourselin S, Boomsma DI, Barkhof F, Visser PJ. White matter hyperintensities and vascular risk factors in monozygotic twins. Neurobiology of Aging. 66: 40-48. PMID 29505954 DOI: 10.1016/J.Neurobiolaging.2018.02.002  1
2018 Vos SB, Micallef C, Barkhof F, Hill A, Winston GP, Ourselin S, Duncan JS. Evaluation of prospective motion correction of high-resolution 3D-T2-FLAIR acquisitions in epilepsy patients. Journal of Neuroradiology. Journal De Neuroradiologie. PMID 29505841 DOI: 10.1016/J.Neurad.2018.02.007  1
2018 Rhodius-Meester HFM, Liedes H, Koene T, Lemstra AW, Teunissen CE, Barkhof F, Scheltens P, van Gils M, Lötjönen J, van der Flier WM. Disease-related determinants are associated with mortality in dementia due to Alzheimer's disease. Alzheimer's Research & Therapy. 10: 23. PMID 29458426 DOI: 10.1186/S13195-018-0348-0  1
2018 Hendriks EJ, Habets EJJ, Taphoorn MJB, Douw L, Zwinderman AH, Vandertop WP, Barkhof F, Klein M, De Witt Hamer PC. Linking late cognitive outcome with glioma surgery location using resection cavity maps. Human Brain Mapping. PMID 29380489 DOI: 10.1002/Hbm.23986  1
2018 Eshaghi A, Prados F, Brownlee W, Altmann DR, Tur C, Cardoso MJ, De Angelis F, van de Pavert SH, Cawley N, De Stefano N, Stromillo ML, Battaglini M, Ruggieri S, Gasperini C, Filippi M, ... ... Barkhof F, et al. Deep grey matter volume loss drives disability worsening in multiple sclerosis. Annals of Neurology. PMID 29331092 DOI: 10.1002/Ana.25145  1
2018 Hagens MH, Burggraaff J, Kilsdonk ID, Ruggieri S, Collorone S, Cortese R, Cawley N, Sbardella E, Andelova M, Amann M, Lieb JM, Pantano P, Lissenberg-Witte BI, Killestein J, Oreja-Guevara C, ... ... Barkhof F, et al. Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517751647. PMID 29327668 DOI: 10.1177/1352458517751647  1
2018 Tur C, Moccia M, Barkhof F, Chataway J, Sastre-Garriga J, Thompson AJ, Ciccarelli O. Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting. Nature Reviews. Neurology. PMID 29326424 DOI: 10.1038/Nrneurol.2017.171  1
2018 Rimkus CM, Schoonheim MM, Steenwijk MD, Vrenken H, Eijlers AJ, Killestein J, Wattjes MP, Leite CC, Barkhof F, Tijms BM. Gray matter networks and cognitive impairment in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517751650. PMID 29320933 DOI: 10.1177/1352458517751650  1
2018 Ingala S, Petr J, Pålhaugen L, Gajdos M, Fladby T, Selnes P, Barkhof F, Bjornerud A, Rektorova I, Mutsaerts HJMM. P1-401: Investigating Arterial Spin Labeling As A Large Vessel Correlate Of Svd, Ad, And Pd Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.410  1
2018 Leeuwis AE, Weaver NA, Biesbroek JM, Kuijf HJ, Hooghiemstra AM, Prins ND, Scheltens P, Barkhof F, Flier WMVd, Biessels GJ. O1-14-04: Impact Of White Matter Hyperintensity Location On Depressive Symptoms In Memory Clinic Patients: A Lesion-Symptom Mapping Study Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.3050  1
2018 Leeuw FAd, Tijms BM, Peeters CFW, Kester MI, Scheltens P, Duijn CMv, Barkhof F, Teunissen CE, Flier WMVd. P1-297: Metabolic Blood-Based Biomarkers Relate To Brain Atrophy And White Matter Hyperintensities In Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.303  1
2018 Kate Mt, Dicks E, Flier WMVd, Teunissen CE, Scheltens P, Barkhof F, Visser PJ, Tijms BM, Initiative ADN, Cohort AD. O5-01-03: Atrophy Subtypes In Alzheimer'S Disease Identified Through Non-Negative Matrix Factorization Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2997  1
2018 Loenhoud ACv, Flier WMVd, Wink AM, Dicks E, Groot C, Twisk JW, Barkhof F, Scheltens P, Ossenkoppele R. The Use Of Residual Methods To Capture Cognitive Reserve And Study Clinical Progression In Alzheimer’S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2987  1
2018 Maurik ISv, Vos SJB, Bos I, Bouwman FH, Tijms BM, Teunissen CE, Barkhof F, Scheltens P, Palmqvist S, Hansson O, Visser PJ, Berkhof J, Flier WMVd. O2-15-04: Robust Individualized Prediction Models Which Are Applicable Across Different Cohorts Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2727  1
2018 Pijnenburg YAL, Vijverberg E, Krudop WA, Gossink FT, Prins ND, Schouws S, Teunissen CE, Barkhof F, Berckel BNMv, Stek ML, Scheltens P, Dols A. O2-14-04: Identifying Behavioral Variant Frontotemporal Dementia Among Patients With A Late-Onset Frontal Lobe Syndrome: Summary Results Of The Lof Study Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2721  1
2018 Salvadó G, Brugulat-Serrat A, Sudre CH, Grau O, Falcon C, Cardoso MJ, Barkhof F, Molinuevo JL, Gispert JD. O2-13-03: Regional Distribution Of White Matter Hyperintensities Related To Alzheimer'S Disease Risk Factors In The Alfa Cohort Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2714  1
2018 Collij L, Heeman F, Konijnenberg E, Braber Ad, Yaqub MM, Visser PJ, Wink AM, Scheltens P, Boellaard R, Berckel BNMv, Schmidt ME, Barkhof F, Alves IL. Extension And Validation Of An Amyloid Staging Model: Associations With Clinical Measures Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2692  1
2018 Hong S, Dobricic V, Smith RG, Küçükali F, Kilpert F, Bos I, Vos SJB, Vandenberghe R, Scheltens P, Engelborghs S, Frisoni GB, Blin O, Richardson J, Bordet R, Tsolaki M, ... ... Barkhof F, et al. F1-02-04: Genomics And Epigenomics Analyses In The Emif-Ad Multimodal Biomarker Discovery Study Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2310  1
2018 Bos I, Vos SJB, Verhey FRJ, Scheltens P, Engelborghs S, Frisoni GB, Blin O, Richardson J, Bordet R, Tsolaki M, Popp J, Martinez-Lage P, Lleó A, Johannsen P, Freund-Levi Y, ... ... Barkhof F, et al. F1-02-01: RELATING CSF MARKERS NEUROGRANIN, NEUROFILAMENT-LIGHT AND YKL-40 TO Aβ, APOE ε4 AND COGNITION: RESULTS FROM THE EMIF-AD MULTIMODAL BIOMARKER DISCOVERY STUDY Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2307  1
2018 Timmers T, Ossenkoppele R, Wolters EE, Visser D, Barkhof F, Golla SSV, Boellaard R, Windhorst AD, Scheltens P, Flier WMVd, Berckel BNMv. Ic-P-222: [18F]Av1451 Pet In Relation To Atrophy Across The Alzheimer'S Disease Spectrum Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2289  1
2018 Loenhoud ACv, Flier WMVd, Wink AM, Dicks E, Groot C, Twisk JW, Barkhof F, Scheltens P, Ossenkoppele R. Disease-Stage Specific Relationship Between Cognitive Reserve And Clinical Progression In Alzheimer’S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2259  1
2018 Ribaldi F, Jovicich J, Ferrari C, Bosch B, Bartrés-Faz D, Müller BW, Wiltfang J, Fiedler U, Montalti M, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, ... ... Barkhof F, et al. Ic-P-126: Volumetric Accuracy Of A Fully Automatic Tool For White Matter Hyperintensities (Wmhs) Segmentation Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2192  1
2018 Jonkman LE, Galis Y, Kaai E, Weerd Lvd, Pouwels PJW, Barkhof F, Rozemuller AM, Geurts JJ, Berg WDJVd. The Normal Aging Brain Collection Amsterdam (Nabca): A Comprehensive Collection Of Postmortem Imaging, Neuropathological And Morphometric Datasets Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2188  1
2018 Singleton EH, Pijnenburg YAL, Sudre CH, Kochova E, Groot C, Papma JM, Ourselin S, Swieten JCv, Barkhof F, Cardoso MJ, Scheltens P, Rabinovici GD, Ossenkoppele R. Ic-P-110: Patterns Of Glucose Hypometabolism, Subcortical Atrophy And White Matter Hyperintensities In The Behavioral Variant Of Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2176  1
2018 Groot C, Yeo T, Vogel JW, Zhang EX, Suna N, Crane PK, Rabinovici GD, Mormino BC, Pijnenburg YAL, Barkhof F, Scheltens P, Flier WMVd, Ossenkoppele R. Ic-P-093: Latent Atrophy Factors In Posterior Cortical Atrophy Relate To Specific Cognitive Impairments Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2157  1
2018 Braber Ad, Stickney K, Ent Dv', Kate Mt, Konijnenberg E, Tomassen J, Barkhof F, Berckel BNMv, Boomsma DI, Geus Ed, Scheltens P, Visser PJ. Ic-P-066: White Matter Microstructure And Amyloid Aggregation In Cognitively Healthy, Elderly Identical Twins Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2131  1
2018 Jonkman LE, Steenwijk MD, Galis Y, Boesen N, Rozemuller AM, Barkhof F, Geurts JJ, Berg WDJVd. Ic-P-053: Lower Structural Degree And Higher Local Efficiency Related To Diffuse Amyloid-Beta Load In Cortex Of Non-Neurological Aged Donors Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2118  1
2018 Collij L, Konijnenberg E, Reimand J, Kate Mt, Braber Ad, Alves IL, Zwan MD, Yaqub MM, Assema Dv, Wink AM, Lammertsma AA, Scheltens P, Visser PJ, Barkhof F, Berckel BNMv. Assessment Of Early Amyloid Pathology Using [18F]Flutemetamol Positron Emission Tomography: Comparing Visual Read, Semi-Quantitative And Quantitative Methods Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2069  1
2018 Tijms BM, Dicks E, Scheltens P, Barkhof F, Flier WMVd. Ic-06-05: Loss Of Grey Matter Connectivity In The Precuneus Is Associated With Faster Atrophy Rates In Preclinical Alzheimer'S Disease Alzheimers & Dementia. 14: 13. DOI: 10.1016/J.Jalz.2018.06.2058  1
2018 Garbarino S, Lorenzi M, Vinke E, Marinescu RV, Oxtoby NP, Eshaghi A, Ikram MA, Niessen WJ, Ciccarelli O, Barkhof F, Vernooij MW, Alexander DC, Initiative ADN. P3-436: Mechanistic Profiles Of Neurodegeneration: A Study In Alzheimer'S Disease, Healthy Ageing And Primary Progressive Multiple Sclerosis Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1799  1
2018 Abaei M, Baas KPA, Petr J, Hill DL, Wolz R, Kuijer J, Sokolska M, Barkhof F, Ourselin S, Duncan J, Vos S, Mutsaerts HJ, Thomas DL. P3-422: Protocol Harmonisation And In-Vivo Comparison Of Arterial Spin Labelling Perfusion Mri For Multicenter Clinical Trials Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1785  1
2018 Dicks E, He Y, Beg F, Biessels GJ, Carmeli C, Chen G, Çiftçi K, Dai Z, Dellen EV, Dyrba M, Friedman EJ, Haan Wd, Jalili M, Jeong J, Jeong Y, ... ... Barkhof F, et al. Ic-P-032: Influence Of Network Construction Methods On Path Length Values In Alzheimer'S Disease: A Multi-Study Analysis Of Mri Connectivity Studies Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1703  1
2018 Jutten RJ, Dicks E, Vermaat LEW, Barkhof F, Scheltens P, Tijms BM, Sikkes SAM. P3-277: Impairment In Complex Activities Of Daily Living Is Related To Neurodegeneration In Alzheimer'S Disease Specific Regions Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1637  1
2018 Kim M, Snowden SG, Ahmad T, Westwood S, Baird AL, Proitsi P, Nevado-Holgado AJ, Hye A, Ashton NJ, Bos I, Vos SJB, Vandenberghe R, Scheltens P, Engelborghs S, Frisoni GB, ... ... Barkhof F, et al. P3-233: PLASMA PRIMARY FATTY AMIDES ASSOCIATE TO CSF AMYLOID LEVELS AND ALZHEIMER\textquotesingleS DISEASE PROGRESSION IN THE EMIF-AD BIOMARKER DISCOVERY COHORT Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1592  1
2018 Legdeur N, Badissi M, Collij L, Heeman F, Berckel BNMv, Barkhof F, Scheltens P, Muller M, Maier AB, Visser PJ. P3-216: Is The Relation Between Blood Pressure And Cognition Dependent On Amyloid Pathology Or Physical Performance? Results Of The Emif-Ad 90+ Study Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1575  1
2018 Brugulat-Serrat A, Salvadó G, Sudre CH, Grau O, Falcon C, Sánchez-Benavides G, Gramunt N, Cardoso MJ, Barkhof F, Molinuevo JL, Gispert JD. P2-505: Regional Distribution Of White Matter Hyperintensity Correlates With Cognition In The Alfa Cohort Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1199  1
2018 Rhodius-Meester HFM, Bruun M, Baroni M, Gjerum L, Remes AM, Urhemaa T, Tolonen A, Rueckert D, Gils Mv, Lemstra E, Barkhof F, Frederiksen KS, Waldemar G, Scheltens P, Soininen H, et al. Different combinations of diagnostic tests discriminate specific subtypes of dementia Alzheimers & Dementia. 10: 820-821. DOI: 10.1016/J.Jalz.2018.06.1039  1
2018 Leijenaar JF, Klaassen ES, Leeuwis AE, Groeneveld GJ, Flier WMVd, Scheltens P, Weinstein HC, Biessels GJ, Barkhof F, Prins ND. Methylphenidate Improves Executive Functioning In Patients With Vascular Cognitive Impairment: First Results Of The Stream-Vci Study Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.017  1
2017 Hacohen Y, Rossor T, Mankad K, Chong W', Lux A, Wassmer E, Lim M, Barkhof F, Ciccarelli O, Hemingway C. 'Leukodystrophy-like' phenotype in children with myelin oligodendrocyte glycoprotein antibody-associated disease. Developmental Medicine and Child Neurology. PMID 29288492 DOI: 10.1111/dmcn.13649  1
2017 Filippi M, Preziosa P, Meani A, Ciccarelli O, Mesaros S, Rovira A, Frederiksen J, Enzinger C, Barkhof F, Gasperini C, Brownlee W, Drulovic J, Montalban X, Cramer SP, Pichler A, et al. Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study. The Lancet. Neurology. PMID 29275979 DOI: 10.1016/S1474-4422(17)30469-6  1
2017 Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet. Neurology. PMID 29275977 DOI: 10.1016/S1474-4422(17)30470-2  1
2017 Groot C, van Loenhoud AC, Barkhof F, van Berckel BNM, Koene T, Teunissen CC, Scheltens P, van der Flier WM, Ossenkoppele R. Differential effects of cognitive reserve and brain reserve on cognition in Alzheimer disease. Neurology. PMID 29237798 DOI: 10.1212/Wnl.0000000000004802  1
2017 Leijenaar JF, van Maurik IS, Kuijer JPA, van der Flier WM, Scheltens P, Barkhof F, Prins ND. Lower cerebral blood flow in subjects with Alzheimer's dementia, mild cognitive impairment, and subjective cognitive decline using two-dimensional phase-contrast magnetic resonance imaging. Alzheimer's & Dementia (Amsterdam, Netherlands). 9: 76-83. PMID 29234724 DOI: 10.1016/J.Dadm.2017.10.001  1
2017 Ostrowitzki S, Lasser RA, Dorflinger E, Scheltens P, Barkhof F, Nikolcheva T, Ashford E, Retout S, Hofmann C, Delmar P, Klein G, Andjelkovic M, Dubois B, Boada M, Blennow K, et al. A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease. Alzheimer's Research & Therapy. 9: 95. PMID 29221491 DOI: 10.1186/S13195-017-0318-Y  1
2017 Wattjes MP, Wijburg MT, Eijk JV, Frequin S, Uitdehaag BMJ, Barkhof F, Warnke C, Killestein J. Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29142146 DOI: 10.1136/Jnnp-2017-316886  1
2017 Sudre CH, Anson BG, Davagnanamd I, Schmitt A, Mendelson AF, Prados F, Smith L, Atkinson D, Hughes AD, Chaturvedi N, Cardoso MJ, Barkhof F, Jaeger HR, Ourselin S. Bullseye's representation of cerebral white matter hyperintensities. Journal of Neuroradiology. Journal De Neuroradiologie. PMID 29132940 DOI: 10.1016/J.Neurad.2017.10.001  1
2017 Dicks E, Tijms BM, Ten Kate M, Gouw AA, Benedictus MR, Teunissen CE, Barkhof F, Scheltens P, van der Flier WM. Gray matter network measures are associated with cognitive decline in mild cognitive impairment. Neurobiology of Aging. 61: 198-206. PMID 29111486 DOI: 10.1016/J.Neurobiolaging.2017.09.029  1
2017 Dekker I, Sombekke MH, Witte BI, Geurts JJ, Barkhof F, Uitdehaag BM, Killestein J, Wattjes MP. Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517736147. PMID 29106327 DOI: 10.1177/1352458517736147  1
2017 Leeuwis AE, Hooghiemstra AM, Amier R, Ferro DA, Franken L, Nijveldt R, Kuijer JPA, Bronzwaer AGT, van Lieshout JJ, Rietberg MB, Veerbeek JM, Huijsmans RJ, Backx FJG, Teunissen CE, Bron EE, ... Barkhof F, et al. Design of the ExCersion-VCI study: The effect of aerobic exercise on cerebral perfusion in patients with vascular cognitive impairment. Alzheimer's & Dementia (New York, N. Y.). 3: 157-165. PMID 29067325 DOI: 10.1016/J.Trci.2017.02.002  1
2017 Barkhof F. The optic nerve should be included as one of the typical CNS regions for establishing dissemination in space when diagnosing MS - Commentary. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517738060. PMID 29058994 DOI: 10.1177/1352458517738060  0.01
2017 van Maurik IS, Zwan MD, Tijms BM, Bouwman FH, Teunissen CE, Scheltens P, Wattjes MP, Barkhof F, Berkhof J, van der Flier WM. Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project. Jama Neurology. PMID 29049480 DOI: 10.1001/Jamaneurol.2017.2712  1
2017 Moccia M, de Stefano N, Barkhof F. Imaging outcome measures for progressive multiple sclerosis trials. Multiple Sclerosis (Houndmills, Basingstoke, England). 23: 1614-1626. PMID 29041865 DOI: 10.1177/1352458517729456  1
2017 Tijms BM, Ten Kate M, Gouw AA, Borta A, Verfaillie S, Teunissen CE, Scheltens P, Barkhof F, van der Flier WM. Gray matter networks and clinical progression in subjects with predementia Alzheimer's disease. Neurobiology of Aging. 61: 75-81. PMID 29040871 DOI: 10.1016/J.Neurobiolaging.2017.09.011  1
2017 Verfaillie SCJ, Slot RE, Tijms BM, Bouwman F, Benedictus MR, Overbeek JM, Koene T, Vrenken H, Scheltens P, Barkhof F, van der Flier WM. Thinner cortex in patients with subjective cognitive decline is associated with steeper decline of memory. Neurobiology of Aging. PMID 29029762 DOI: 10.1016/J.Neurobiolaging.2017.09.009  1
2017 Ten Kulve JS, Veltman DJ, Gerdes VEA, van Bloemendaal L, Barkhof F, Deacon CF, Holst JJ, Drent ML, Diamant M, IJzerman RG. Elevated Postoperative Endogenous GLP-1 Levels Mediate Effects of Roux-en-Y Gastric Bypass on Neural Responsivity to Food Cues. Diabetes Care. PMID 29025878 DOI: 10.2337/Dc16-2113  1
2017 Lee CY, Mak HK, Chiu PW, Chang HC, Barkhof F, Chan KH. Differential brainstem atrophy patterns in multiple sclerosis and neuromyelitis optica spectrum disorders. Journal of Magnetic Resonance Imaging : Jmri. PMID 28990252 DOI: 10.1002/Jmri.25866  1
2017 Martens RM, Bechten A, Ingala S, van Schijndel RA, Machado VB, de Jong MC, Sanchez E, Purcell D, Arrighi MH, Brashear RH, Wattjes MP, Barkhof F. The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer's patients: An interobserver study. European Radiology. PMID 28956123 DOI: 10.1007/S00330-017-5022-6  1
2017 de Sitter A, Steenwijk MD, Ruet A, Versteeg A, Liu Y, van Schijndel RA, Pouwels PJW, Kilsdonk ID, Cover KS, van Dijk BW, Ropele S, Rocca MA, Yiannakas M, Wattjes MP, Damangir S, ... ... Barkhof F, et al. Performance of five research-domain automated WM lesion segmentation methods in a multi-center MS study. Neuroimage. PMID 28899746 DOI: 10.1016/J.Neuroimage.2017.09.011  1
2017 Ten Kate M, Barkhof F, Visser PJ, Teunissen CE, Scheltens P, van der Flier WM, Tijms BM. Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment. Alzheimer's Research & Therapy. 9: 73. PMID 28899429 DOI: 10.1186/S13195-017-0299-X  1
2017 Haller S, Barkhof F, Thomas D, Lovblad KO, Golay X, Zaharchuk G. Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan: Response. Radiology. 284: 301-303. PMID 28896007 DOI: 10.1148/radiol.2017170252  1
2017 Verburg N, Hoefnagels FWA, Barkhof F, Boellaard R, Goldman S, Guo J, Heimans JJ, Hoekstra OS, Jain R, Kinoshita M, Pouwels PJW, Price SJ, Reijneveld JC, Stadlbauer A, Vandertop WP, et al. Diagnostic Accuracy of Neuroimaging to Delineate Diffuse Gliomas within the Brain: A Meta-Analysis. Ajnr. American Journal of Neuroradiology. PMID 28882867 DOI: 10.3174/Ajnr.A5368  1
2017 Steenwijk MD, Amiri H, Schoonheim MM, de Sitter A, Barkhof F, Pouwels PJW, Vrenken H. Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy. Neuroimage. Clinical. 15: 843-853. PMID 28794970 DOI: 10.1016/J.Nicl.2017.06.034  1
2017 Liu Y, Jiang X, Butzkueven H, Duan Y, Huang J, Ren Z, Dong H, Shi FD, Barkhof F, Li K, Wang J. Multimodal characterization of gray matter alterations in neuromyelitis optica. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517721053. PMID 28741987 DOI: 10.1177/1352458517721053  1
2017 Frisoni GB, Boccardi M, Barkhof F, Blennow K, Cappa S, Chiotis K, Démonet JF, Garibotto V, Giannakopoulos P, Gietl A, Hansson O, Herholz K, Jack CR, Nobili F, Nordberg A, et al. Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers. The Lancet. Neurology. 16: 661-676. PMID 28721928 DOI: 10.1016/S1474-4422(17)30159-X  1
2017 Liu Y, Duan Y, Huang J, Ren Z, Liu Z, Dong H, Weiler F, Hahn HK, Shi FD, Butzkueven H, Barkhof F, Li K. Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MS. European Radiology. PMID 28667482 DOI: 10.1007/S00330-017-4921-X  1
2017 Tong T, Ledig C, Guerrero R, Schuh A, Koikkalainen J, Tolonen A, Rhodius H, Barkhof F, Tijms B, Lemstra AW, Soininen H, Remes AM, Waldemar G, Hasselbalch S, Mecocci P, et al. Five-class differential diagnostics of neurodegenerative diseases using random undersampling boosting. Neuroimage. Clinical. 15: 613-624. PMID 28664032 DOI: 10.1016/J.Nicl.2017.06.012  1
2017 van Loenhoud AC, Wink AM, Groot C, Verfaillie SCJ, Twisk J, Barkhof F, van Berckel B, Scheltens P, van der Flier WM, Ossenkoppele R. A neuroimaging approach to capture cognitive reserve: Application to Alzheimer's disease. Human Brain Mapping. PMID 28631336 DOI: 10.1002/Hbm.23695  1
2017 Hoefnagels FWA, de Witt Hamer PC, Pouwels PJW, Barkhof F, Vandertop WP. Impact of gradient number and voxel size on DTI tractography for resective brain surgery. World Neurosurgery. PMID 28624562 DOI: 10.1016/J.Wneu.2017.06.050  1
2017 Hacohen Y, Mankad K, Chong WK, Barkhof F, Vincent A, Lim M, Wassmer E, Ciccarelli O, Hemingway C. Diagnostic algorithm for relapsing acquired demyelinating syndromes in children. Neurology. PMID 28615429 DOI: 10.1212/Wnl.0000000000004117  1
2017 Doornweerd S, De Geus EJ, Barkhof F, Van Bloemendaal L, Boomsma DI, Van Dongen J, Drent ML, Willemsen G, Veltman DJ, IJzerman RG. Brain reward responses to food stimuli among female monozygotic twins discordant for BMI. Brain Imaging and Behavior. PMID 28597337 DOI: 10.1007/S11682-017-9711-1  1
2017 Cavedo E, Lista S, Rojkova K, Andrea Chiesa P, Houot M, Brueggen K, Blautzik J, Bokde ALW, Dubois B, Barkhof F, Pouwels PJW, Teipel S, Hampel H. Disrupted white matter structural networks in healthy older adults APOE ε4 carriers - An International Multicenter DTI Study. Neuroscience. PMID 28596117 DOI: 10.1016/J.Neuroscience.2017.05.048  1
2017 Vrij-van den Bos S, Hol JA, La Piana R, Harting I, Vanderver A, Barkhof F, Cayami F, van Wieringen WN, Pouwels PJW, van der Knaap MS, Bernard G, Wolf NI. 4H Leukodystrophy: A Brain Magnetic Resonance Imaging Scoring System. Neuropediatrics. 48: 152-160. PMID 28561206 DOI: 10.1055/S-0037-1599141  1
2017 Rhodius-Meester HFM, Benedictus MR, Wattjes MP, Barkhof F, Scheltens P, Muller M, van der Flier WM. MRI Visual Ratings of Brain Atrophy and White Matter Hyperintensities across the Spectrum of Cognitive Decline Are Differently Affected by Age and Diagnosis. Frontiers in Aging Neuroscience. 9: 117. PMID 28536518 DOI: 10.3389/Fnagi.2017.00117  1
2017 Harper L, Bouwman F, Burton EJ, Barkhof F, Scheltens P, O'Brien JT, Fox NC, Ridgway GR, Schott JM. Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28473626 DOI: 10.1136/Jnnp-2016-314978  1
2017 Meijer KA, Eijlers AJC, Douw L, Uitdehaag BMJ, Barkhof F, Geurts JJG, Schoonheim MM. Increased connectivity of hub networks and cognitive impairment in multiple sclerosis. Neurology. PMID 28468841 DOI: 10.1212/Wnl.0000000000003982  1
2017 Hagens MH, Killestein J, Yaqub MM, van Dongen GA, Lammertsma AA, Barkhof F, van Berckel BN. Cerebral rituximab uptake in multiple sclerosis: A (89)Zr-immunoPET pilot study. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517704507. PMID 28443358 DOI: 10.1177/1352458517704507  1
2017 van Duinkerken E, Schoonheim MM, IJzerman RG, Moll AC, Landeira-Fernandez J, Klein M, Diamant M, Snoek FJ, Barkhof F, Wink AM. Altered eigenvector centrality is related to local resting-state network functional connectivity in patients with longstanding type 1 diabetes mellitus. Human Brain Mapping. PMID 28429383 DOI: 10.1002/Hbm.23617  1
2017 Boomsma JMF, Exalto LG, Barkhof F, van den Berg E, de Bresser J, Heinen R, Koek HL, Prins ND, Scheltens P, Weinstein HC, van der Flier WM, Biessels GJ. Vascular Cognitive Impairment in a Memory Clinic Population: Rationale and Design of the "Utrecht-Amsterdam Clinical Features and Prognosis in Vascular Cognitive Impairment" (TRACE-VCI) Study. Jmir Research Protocols. 6: e60. PMID 28428166 DOI: 10.2196/Resprot.6864  1
2017 Scheltens NME, Tijms BM, Koene T, Barkhof F, Teunissen CE, Wolfsgruber S, Wagner M, Kornhuber J, Peters O, Cohn-Sheehy BI, Rabinovici GD, Miller BL, Kramer JH, Scheltens P, van der Flier WM, et al. Cognitive subtypes of probable Alzheimer's disease robustly identified in four cohorts. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28427934 DOI: 10.1016/J.Jalz.2017.03.002  1
2017 Klauser AM, Wiebenga OT, Eijlers AJ, Schoonheim MM, Uitdehaag BM, Barkhof F, Pouwels PJ, Geurts JJ. Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517702534. PMID 28406063 DOI: 10.1177/1352458517702534  1
2017 Fällmar D, Haller S, Lilja J, Danfors T, Kilander L, Tolboom N, Egger K, Kellner E, Croon PM, Verfaillie SC, van Berckel BN, Ossenkoppele R, Barkhof F, Larsson EM. Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET. European Radiology. PMID 28374078 DOI: 10.1007/S00330-017-4784-1  1
2017 Ten Kate M, Barkhof F, Boccardi M, Visser PJ, Jack CR, Lovblad KO, Frisoni GB, Scheltens P. Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiology of Aging. 52: 167-182.e1. PMID 28317647 DOI: 10.1016/J.Neurobiolaging.2016.05.024  1
2017 Ketter N, Brashear HR, Bogert J, Di J, Miaux Y, Gass A, Purcell DD, Barkhof F, Arrighi HM. Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients. Journal of Alzheimer's Disease : Jad. PMID 28269765 DOI: 10.3233/Jad-160216  1
2017 Vrij-van den Bos S, Hol JA, La Piana R, Harting I, Vanderver A, Barkhof F, Cayami F, van Wieringen WN, Pouwels PJ, van der Knaap MS, Bernard G, Wolf NI. 4H Leukodystrophy: A Brain Magnetic Resonance Imaging Scoring System. Neuropediatrics. PMID 28249300 DOI: 10.1055/s-0037-1599141  1
2017 de Wilde A, van Maurik IS, Kunneman M, Bouwman F, Zwan M, Willemse EA, Biessels GJ, Minkman M, Pel R, Schoonenboom NS, Smets EM, Wattjes MP, Barkhof F, Stephens A, van Lier EJ, et al. Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design. Alzheimer's & Dementia (Amsterdam, Netherlands). 6: 143-151. PMID 28239639 DOI: 10.1016/J.Dadm.2017.01.003  1
2017 Sudre CH, Cardoso MJ, Frost C, Barnes J, Barkhof F, Fox N, Ourselin S. APOE ε4 status is associated with white matter hyperintensities volume accumulation rate independent of AD diagnosis. Neurobiology of Aging. 53: 67-75. PMID 28235680 DOI: 10.1016/J.Neurobiolaging.2017.01.014  1
2017 Bartel F, Vrenken H, Bijma F, Barkhof F, van Herk M, de Munck JC. Regional analysis of volumes and reproducibilities of automatic and manual hippocampal segmentations. Plos One. 12: e0166785. PMID 28182655 DOI: 10.1371/Journal.Pone.0166785  1
2017 Eijlers AJ, Meijer KA, Wassenaar TM, Steenwijk MD, Uitdehaag BM, Barkhof F, Wink AM, Geurts JJ, Schoonheim MM. Increased default-mode network centrality in cognitively impaired multiple sclerosis patients. Neurology. PMID 28179464 DOI: 10.1212/Wnl.0000000000003689  1
2017 Derks J, Dirkson AR, de Witt Hamer PC, van Geest Q, Hulst HE, Barkhof F, Pouwels PJ, Geurts JJ, Reijneveld JC, Douw L. Connectomic profile and clinical phenotype in newly diagnosed glioma patients. Neuroimage. Clinical. 14: 87-96. PMID 28154795 DOI: 10.1016/J.Nicl.2017.01.007  1
2017 van Zanten SE, Baugh J, Chaney B, De Jongh D, Aliaga ES, Barkhof F, Noltes J, De Wolf R, Van Dijk J, Cannarozzo A, Damen-Korbijn CM, Lieverst JA, Colditz N, Hoffmann M, Warmuth-Metz M, et al. Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease. Journal of Neuro-Oncology. PMID 28110411 DOI: 10.1007/S11060-016-2363-Y  1
2017 Bechten A, Wattjes MP, Purcell DD, Aliaga ES, Daams M, Brashear HR, Arrighi HM, Barkhof F. Validation of an MRI Rating Scale for Amyloid-Related Imaging Abnormalities. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 28102639 DOI: 10.1111/Jon.12422  1
2017 Haller S, Barkhof F. Interaction of Vascular Damage and Alzheimer Dementia: Focal Damage and Disconnection. Radiology. 282: 311-313. PMID 28099102 DOI: 10.1148/Radiol.2016161564  1
2017 Selmaj K, Barkhof F, Belova AN, Wolf C, van den Tweel ER, Oberyé JJ, Mulder R, Egging DF, Koper NP, Cohen JA. Switching from branded to generic glatiramer acetate: 15-month GATE trial extension results. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458516688956. PMID 28090798 DOI: 10.1177/1352458516688956  1
2017 Salome M, Barkhof F, Visser L. Hirayama disease; an atypical clinical manifestation of a cervical myelopathy with typical MRI features. Bmj Case Reports. 2017. PMID 28052949 DOI: 10.1136/Bcr-2016-217780  0.01
2017 Lee CY, Kate MT, Kuijer J, Barkhof F. Arterial spin labeled cerebral perfusion in cognitively normal monozygotic twins Journal of the Neurological Sciences. 381: 804. DOI: 10.1016/J.Jns.2017.08.2264  1
2017 Wilde Ad, Pelkmans W, Bouwman FH, Verwer J, Groot C, Buchem Mv, Zwan MD, Ossenkoppele R, Yaqub MM, Kunneman M, Smets EM, Barkhof F, Lammertsma AA, Stephens A, Lier Ev, et al. The Impact Of Amyloid Pet On Diagnosis And Patient Management In An Unselected Memory Clinic Cohort: The Abide Project Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.08.004  1
2017 Rhodius-Meester HFM, Liedes H, Wolfsgruber S, Coll-Padros N, Koikkalainen J, Kornhuber J, Peters O, Jessen F, Kleineidam L, Molinuevo JL, Rami L, Teunissen CE, Barkhof F, Sikkes SAM, Wesselman LMP, et al. Prognosis Of Clinical Progression In Subjective Cognitive Decline Using A Clinical Decision Support System Alzheimers & Dementia. 13: 579. DOI: 10.1016/J.Jalz.2017.07.203  1
2017 Slot RER, Verfaillie SCJ, Overbeek JM, Timmers T, Wesselman LMP, Bouwman FH, Prins ND, Teunissen CE, Dols A, Barkhof F, Berckel BNMv, Scheltens P, Sikkes SAM, Flier WMvd. Characterizing Individuals With Subjective Cognitive Decline: The Subjective Cognitive Impairment Cohort (Science) Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.07.143  1
2017 Maurik ISv, Slot RER, Verfaillie SCJ, Bouwman FH, Teunissen CE, Scheltens P, Barkhof F, Wattjes MP, Berkhof J, Flier WMvd. Biomarker-Based Personalized Risk Estimates For Patients With Subjective Cognitive Decline Alzheimers & Dementia. 13: 177. DOI: 10.1016/J.Jalz.2017.07.022  1
2017 Haan Jd, Kreeke Avd, Verbraak F, Nadyarnykh O, Teunissen CE, Barkhof F, Berckel BNMv, Scheltens P, Bouwman FH, Boer Jd. Amyloid Visualization In The Retina Of Alzheimer’S Disease Patients With Curcumin Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.897  1
2017 Bos I, Vos SJB, Vandenberghe R, Scheltens P, Engelborghs S, Frisoni GB, Molinuevo JL, Wallin A, Lleó A, Popp J, Martinez-Lage P, Baird AL, Legido-Quigley C, Bertram L, Barkhof F, et al. European Medical Information Framework For Alzheimer’S Disease (Emif-Ad): The Biomarker Discovery Study Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.864  1
2017 Ribaldi F, Marizzoni M, Jovicich J, Ferrari C, Bosch B, Bartrés-Faz D, Müller BW, Wiltfang J, Fiedler U, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, ... ... Barkhof F, et al. Across-Session Reproducibility Of Automatic White Matter Hyperintensities Segmentation: A European Multi-Site 3T Study Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2542  1
2017 Bouts MJRJ, Möller C, Hafkemeijer A, Swieten JCv, Dopper EGP, Flier WMvd, Vrenken H, Wink AM, Pijnenburg YAL, Scheltens P, Barkhof F, Grond Jvd, Rooij Md, Rombouts SARB. Mri-Based Classification Accuracy Of Dementia Type Is Determined By Mri Modality Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2404  1
2017 Verfaillie SCJ, Slot RER, Dicks E, Prins ND, Overbeek JM, Scheltens P, Barkhof F, Flier WMvd, Tijms BM. Grey Matter Connectivity Is Related To A Steeper Loss Of Memory And Language Functioning Over Time In Patients With Subjective Cognitive Decline Alzheimers & Dementia. 13: 451. DOI: 10.1016/J.Jalz.2017.06.2384  1
2017 Kate Mt, Sudre CH, Braber Ad, Konijnenberg E, Cardoso MJ, Scheltens P, Ourselin S, Boomsma DI, Barkhof F, Visser PJ. White Matter Hyperintensities And Vascular Risk Factors In Cognitively Healthy Elderly Monozygotic Twin Pairs Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2338  1
2017 Groot C, Weijden CWJvd, Flier WMvd, Loenhoud ACv, Berckel BNMv, Barkhof F, Koene T, Teunissen CE, Scheltens P, Ossenkoppele R. EFFECT OF APOE-ε2 ON REGIONAL GRAY MATTER ATROPHY AND CLINICAL PHENOTYPE IN ALZHEIMER’S DISEASE Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2328  1
2017 Braber Ad, Prent N, Kate Mt, Konijnenberg E, Barkhof F, Berckel BNMv, Scheltens P, Boomsma DI, Visser PJ. Early Alterations In Resting-State Functional Connectivity Is Associated With Amyloid Pathology In Cognitively Healthy Elderly Monozygotic Twins Alzheimers & Dementia. 13: 429. DOI: 10.1016/J.Jalz.2017.06.2326  1
2017 Redolfi A, Kate Mt, Peira E, Orlandi D, Wolz R, Lovestone S, Visser PJ, Barkhof F, Frisoni GB. Best Combinatorial Low-Cost Markers To Predict Mci Conversion: An Emif-Ad Federation Study Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2094  1
2017 Leijenaar JF, Pelkmans W, Rozemuller A, Bouwman FH, Flier WMvd, Scheltens P, Barkhof F, Prins ND. Clinical And Radiological Findings In Patients With Pathologically Confirmed Caa Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.1639  1
2017 Lotjonen J, Koikkalainen J, Meester HFR, Flier WMvd, Scheltens P, Barkhof F, Erkinjuntti T. Computed Rating Scales For Cognitive Disorders From Mri Alzheimers & Dementia. 13: 1108. DOI: 10.1016/J.Jalz.2017.06.1602  1
2017 Dicks E, Tijms BM, Gouw AA, Benedictus MR, Barkhof F, Scheltens P, Flier WMvd. Grey Matter Connectivity Is Associated With The Rate Of Cognitive Decline In Mild Cognitive Impairment Alzheimers & Dementia. 13: 69. DOI: 10.1016/J.Jalz.2017.06.1591  1
2017 Kate Mt, Tijms BM, Konijnenberg E, Braber Ad, Boomsma DI, Scheltens P, Barkhof F, Visser PJ. Correlation Of Grey Matter Network Measures In Cognitively Healthy Elderly Monozygotic Twin Pairs Alzheimers & Dementia. 13: 783. DOI: 10.1016/J.Jalz.2017.06.1054  1
2016 Rimkus CM, Steenwijk MD, Barkhof F. Causes, effects and connectivity changes in MS-related cognitive decline. Dementia & Neuropsychologia. 10: 2-11. PMID 29213424 DOI: 10.1590/S1980-57642016DN10100002  1
2016 Scheltens NME, Kuyper IS, Boellaard R, Barkhof F, Teunissen CE, Broersen LM, Lansbergen MM, van der Flier WM, van Berckel BNM, Scheltens P. Design of the NL-ENIGMA study: Exploring the effect of Souvenaid on cerebral glucose metabolism in early Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 2: 233-240. PMID 29067310 DOI: 10.1016/J.Trci.2016.07.004  1
2016 Verfaillie SC, Tijms B, Versteeg A, Benedictus MR, Bouwman FH, Scheltens P, Barkhof F, Vrenken H, van der Flier WM. Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline. Alzheimer's & Dementia (Amsterdam, Netherlands). 5: 43-52. PMID 28054027 DOI: 10.1016/J.Dadm.2016.10.007  1
2016 Comi G, De Stefano N, Freedman MS, Barkhof F, Uitdehaag BM, de Vos M, Marhardt K, Chen L, Issard D, Kappos L. Subcutaneous interferon β-1a in the treatment of clinically isolated syndromes: 3-year and 5-year results of the phase III dosing frequency-blind multicentre REFLEXION study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28039317 DOI: 10.1136/Jnnp-2016-314843  1
2016 Hulst HE, Goldschmidt T, Nitsche MA, de Wit SJ, van den Heuvel OA, Barkhof F, Paulus W, van der Werf YD, Geurts JJ. rTMS affects working memory performance, brain activation and functional connectivity in patients with multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27974394 DOI: 10.1136/Jnnp-2016-314224  1
2016 Jokinen H, Melkas S, Madureira S, Verdelho A, Ferro JM, Fazekas F, Schmidt R, Scheltens P, Barkhof F, Wardlaw JM, Inzitari D, Pantoni L, Erkinjuntti T. Cognitive reserve moderates long-term cognitive and functional outcome in cerebral small vessel disease. Journal of Neurology, Neurosurgery, and Psychiatry. 87: 1296-1302. PMID 27951523 DOI: 10.1136/Jnnp-2016-313914  1
2016 Vijverberg EG, Tijms BM, Dopp J, Hong YJ, Teunissen CE, Barkhof F, Scheltens P, Pijnenburg YA. Gray matter network differences between behavioral variant frontotemporal dementia and Alzheimer's disease. Neurobiology of Aging. 50: 77-86. PMID 27940352 DOI: 10.1016/J.Neurobiolaging.2016.11.005  1
2016 Louwersheimer E, Cohn-Hokke PE, Pijnenburg YA, Weiss MM, Sistermans EA, Rozemuller AJ, Hulsman M, van Swieten JC, van Duijn CM, Barkhof F, Koene T, Scheltens P, Van der Flier WM, Holstege H. Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity. Journal of Alzheimer's Disease : Jad. PMID 27911290 DOI: 10.3233/Jad-160091  1
2016 Dols A, Bouckaert F, Sienaert P, Rhebergen D, Vansteelandt K, Ten Kate M, de Winter FL, Comijs HC, Emsell L, Oudega ML, van Exel E, Schouws S, Obbels J, Wattjes M, Barkhof F, et al. Early- and Late-Onset Depression in Late Life: A Prospective Study on Clinical and Structural Brain Characteristics and Response to Electroconvulsive Therapy. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 27771245 DOI: 10.1016/J.Jagp.2016.09.005  1
2016 Haller S, Zaharchuk G, Thomas DL, Lovblad KO, Barkhof F, Golay X. Arterial Spin Labeling Perfusion of the Brain: Emerging Clinical Applications. Radiology. 281: 337-356. PMID 27755938 DOI: 10.1148/Radiol.2016150789  1
2016 Leeuwis AE, Benedictus MR, Kuijer JP, Binnewijzend MA, Hooghiemstra AM, Verfaillie SC, Koene T, Scheltens P, Barkhof F, Prins ND, van der Flier WM. Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27693109 DOI: 10.1016/J.Jalz.2016.08.013  1
2016 Freeze WM, Jacobs HI, Gronenschild EH, Jansen JF, Burgmans S, Aalten P, Clerx L, Vos SJ, van Buchem MA, Barkhof F, van der Flier WM, Verbeek MM, Rikkert MO, Backes WH, Verhey FR, et al. White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β. Journal of Alzheimer's Disease : Jad. PMID 27662299 DOI: 10.3233/Jad-160474  1
2016 Hafkemeijer A, Möller C, Dopper EG, Jiskoot LC, van den Berg-Huysmans AA, van Swieten JC, van der Flier WM, Vrenken H, Pijnenburg YA, Barkhof F, Scheltens P, van der Grond J, Rombouts SA. A Longitudinal Study on Resting State Functional Connectivity in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27662284 DOI: 10.3233/Jad-150695  1
2016 Wijburg MT, Witte BI, Vennegoor A, Roosendaal SD, Sanchez E, Liu Y, Martins Jarnalo CO, Uitdehaag BM, Barkhof F, Killestein J, Wattjes MP. MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27530808 DOI: 10.1136/Jnnp-2016-313772  1
2016 Kappos L, Edan G, Freedman MS, Montalbán X, Hartung HP, Hemmer B, Fox EJ, Barkhof F, Schippling S, Schulze A, Pleimes D, Pohl C, Sandbrink R, Suarez G, Wicklein EM, et al. The 11-year long-term follow-up study from the randomized BENEFIT CIS trial. Neurology. PMID 27511182 DOI: 10.1212/Wnl.0000000000003078  1
2016 Verburg N, Pouwels PJ, Boellaard R, Barkhof F, Hoekstra OS, Reijneveld JC, Vandertop WP, Wesseling P, de Witt Hamer PC. Accurate Delineation of Glioma Infiltration by Advanced PET/MR Neuro-Imaging (FRONTIER Study): A Diagnostic Study Protocol. Neurosurgery. PMID 27479710 DOI: 10.1227/Neu.0000000000001355  1
2016 Steenweg ME, Wolf NI, van Wieringen WN, Barkhof F, van der Knaap MS, Pouwels PJ. Quantitative MRI in hypomyelinating disorders: Correlation with motor handicap. Neurology. PMID 27440150 DOI: 10.1212/Wnl.0000000000003000  1
2016 Sormani MP, Kappos L, Radue EW, Cohen J, Barkhof F, Sprenger T, Piani Meier D, Häring D, Tomic D, De Stefano N. Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27411701 DOI: 10.1177/1352458516659550  1
2016 Shu N, Duan Y, Xia M, Schoonheim MM, Huang J, Ren Z, Sun Z, Ye J, Dong H, Shi FD, Barkhof F, Li K, Liu Y. Disrupted topological organization of structural and functional brain connectomes in clinically isolated syndrome and multiple sclerosis. Scientific Reports. 6: 29383. PMID 27403924 DOI: 10.1038/Srep29383  1
2016 Collij LE, Heeman F, Kuijer JP, Ossenkoppele R, Benedictus MR, Möller C, Verfaillie SC, Sanz-Arigita EJ, van Berckel BN, van der Flier WM, Scheltens P, Barkhof F, Wink AM. Application of Machine Learning to Arterial Spin Labeling in Mild Cognitive Impairment and Alzheimer Disease. Radiology. 152703. PMID 27383395 DOI: 10.1148/Radiol.2016152703  1
2016 Vijverberg EG, Wattjes MP, Dols A, Krudop WA, Möller C, Peters A, Kerssens CJ, Gossink F, Prins ND, Stek ML, Scheltens P, van Berckel BN, Barkhof F, Pijnenburg YA. Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes. Journal of Alzheimer's Disease : Jad. PMID 27372646 DOI: 10.3233/Jad-160285  1
2016 Chételat G, Ossenkoppele R, Villemagne VL, Perrotin A, Landeau B, Mézenge F, Jagust WJ, Dore V, Miller BL, Egret S, Seeley WW, van der Flier WM, La Joie R, Ames D, van Berckel BN, ... ... Barkhof F, et al. Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease. Brain : a Journal of Neurology. PMID 27357349 DOI: 10.1093/Brain/Aww159  1
2016 Barkhof F. Brain atrophy measurements should be used to guide therapy monitoring in MS - NO. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27335096 DOI: 10.1177/1352458516649452  0.01
2016 Benedictus MR, Leeuwis AE, Binnewijzend MA, Kuijer JP, Scheltens P, Barkhof F, van der Flier WM, Prins ND. Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease. European Radiology. PMID 27334014 DOI: 10.1007/S00330-016-4450-Z  1
2016 Cohn-Hokke PE, Holstege H, Weiss MM, van der Flier WM, Barkhof F, Sistermans EA, Pijnenburg YA, van Swieten JC, Meijers-Heijboer H, Scheltens P. A novel CCM2 variant in a family with non-progressive cognitive complaints and cerebral microbleeds. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. PMID 27277535 DOI: 10.1002/Ajmg.B.32468  1
2016 Cover KS, van Schijndel RA, Versteeg A, Leung KK, Mulder ER, Jong RA, Visser PJ, Redolfi A, Revillard J, Grenier B, Manset D, Damangir S, Bosco P, Vrenken H, van Dijk BW, ... ... Barkhof F, et al. Reproducibility of hippocampal atrophy rates measured with manual, FreeSurfer, AdaBoost, FSL/FIRST and the MAPS-HBSI methods in Alzheimer's disease. Psychiatry Research. 252: 26-35. PMID 27179313 DOI: 10.1016/J.Pscychresns.2016.04.006  1
2016 Vijverberg EG, Dols A, Krudop WA, Peters A, Kerssens CJ, van Berckel BN, Wattjes MP, Barkhof F, Gossink F, Prins ND, Stek ML, Scheltens P, Pijnenburg YA. Diagnostic Accuracy of the Frontotemporal Dementia Consensus Criteria in the Late-Onset Frontal Lobe Syndrome. Dementia and Geriatric Cognitive Disorders. 41: 210-9. PMID 27160162 DOI: 10.1159/000444849  1
2016 van Duinkerken E, Ryan CM, Schoonheim MM, Barkhof F, Klein M, Moll AC, Diamant M, IJzerman RG, Snoek FJ. Subgenual Cingulate Cortex Functional Connectivity in Relation to Depressive Symptoms and Cognitive Functioning in Type 1 Diabetes Mellitus Patients. Psychosomatic Medicine. PMID 27136504 DOI: 10.1097/Psy.0000000000000335  1
2016 Koikkalainen J, Rhodius-Meester H, Tolonen A, Barkhof F, Tijms B, Lemstra AW, Tong T, Guerrero R, Schuh A, Ledig C, Rueckert D, Soininen H, Remes AM, Waldemar G, Hasselbalch S, et al. Differential diagnosis of neurodegenerative diseases using structural MRI data. Neuroimage. Clinical. 11: 435-49. PMID 27104138 DOI: 10.1016/J.Nicl.2016.02.019  1
2016 Hagens M, van Berckel B, Barkhof F. Novel MRI and PET markers of neuroinflammation in multiple sclerosis. Current Opinion in Neurology. PMID 27058220 DOI: 10.1097/Wco.0000000000000326  1
2016 Brueggen K, Grothe MJ, Dyrba M, Fellgiebel A, Fischer F, Filippi M, Agosta F, Nestor P, Meisenzahl E, Blautzik J, Frölich L, Hausner L, Bokde AL, Frisoni G, Pievani M, ... ... Barkhof F, et al. The European DTI Study on Dementia - A multicenter DTI and MRI study on Alzheimer's disease and Mild Cognitive Impairment. Neuroimage. PMID 27046114 DOI: 10.1016/J.Neuroimage.2016.03.067  1
2016 Marchitelli R, Minati L, Marizzoni M, Bosch B, Bartrés-Faz D, Müller BW, Wiltfang J, Fiedler U, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, Bordet R, ... ... Barkhof F, et al. Test-retest reliability of the default mode network in a multi-centric fMRI study of healthy elderly: Effects of data-driven physiological noise correction techniques. Human Brain Mapping. PMID 26990928 DOI: 10.1002/Hbm.23157  1
2016 Wiebenga OT, Schoonheim MM, Hulst HE, Nagtegaal GJ, Strijbis EM, Steenwijk MD, Polman CH, Pouwels PJ, Barkhof F, Geurts JJ. White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis. Ajnr. American Journal of Neuroradiology. PMID 26965463 DOI: 10.3174/Ajnr.A4690  1
2016 Kilsdonk ID, Jonkman LE, Klaver R, van Veluw SJ, Zwanenburg JJ, Kuijer JP, Pouwels PJ, Twisk JW, Wattjes MP, Luijten PR, Barkhof F, Geurts JJ. Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study. Brain : a Journal of Neurology. PMID 26956422 DOI: 10.1093/Brain/Aww037  1
2016 Popescu V, Klaver R, Versteeg A, Voorn P, Twisk JW, Barkhof F, Geurts JJ, Vrenken H. Postmortem validation of MRI cortical volume measurements in MS. Human Brain Mapping. PMID 26945922 DOI: 10.1002/Hbm.23168  1
2016 Harper L, Fumagalli GG, Barkhof F, Scheltens P, O'Brien JT, Bouwman F, Burton EJ, Rohrer JD, Fox NC, Ridgway GR, Schott JM. MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases. Brain : a Journal of Neurology. PMID 26936938 DOI: 10.1093/Brain/Aww005  1
2016 Preziosa P, Rocca MA, Pagani E, Stromillo ML, Enzinger C, Gallo A, Hulst HE, Atzori M, Pareto D, Riccitelli GC, Copetti M, De Stefano N, Fazekas F, Bisecco A, Barkhof F, et al. Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study. Human Brain Mapping. PMID 26833969 DOI: 10.1002/Hbm.23125  1
2016 Möller C, Hafkemeijer A, Pijnenburg YA, Rombouts SA, van der Grond J, Dopper E, van Swieten J, Versteeg A, Steenwijk MD, Barkhof F, Scheltens P, Vrenken H, van der Flier WM. Different patterns of cortical gray matter loss over time in behavioral variant frontotemporal dementia and Alzheimer's disease. Neurobiology of Aging. 38: 21-31. PMID 26827640 DOI: 10.1016/J.Neurobiolaging.2015.10.020  1
2016 Ten Kate M, Sanz-Arigita EJ, Tijms BM, Wink AM, Clerigue M, Garcia-Sebastian M, Izagirre A, Ecay-Torres M, Estanga A, Villanua J, Vrenken H, Visser PJ, Martinez-Lage P, Barkhof F. Impact of APOE-ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults. Neurobiology of Aging. 38: 14-20. PMID 26827639 DOI: 10.1016/J.Jalz.2015.06.130  1
2016 Filippi M, Rocca MA, Ciccarelli O, De Stefano N, Evangelou N, Kappos L, Rovira A, Sastre-Garriga J, Tintorè M, Frederiksen JL, Gasperini C, Palace J, Reich DS, Banwell B, Montalban X, ... Barkhof F, et al. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. The Lancet. Neurology. PMID 26822746 DOI: 10.1016/S1474-4422(15)00393-2  1
2016 van Bloemendaal L, Ijzerman RG, Ten Kulve JS, Barkhof F, Diamant M, Veltman DJ, van Duinkerken E. Alterations in white matter volume and integrity in obesity and type 2 diabetes. Metabolic Brain Disease. PMID 26815786 DOI: 10.1007/S11011-016-9792-3  1
2016 Ten Kulve JS, Veltman DJ, van Bloemendaal L, Groot PF, Ruhé HG, Barkhof F, Diamant M, Ijzerman RG. Endogenous GLP-1 and GLP-1 analogue alter CNS responses to palatable food consumption. The Journal of Endocrinology. PMID 26769912 DOI: 10.1530/Joe-15-0461  1
2016 Zhang Y, Jonkman L, Klauser A, Barkhof F, Yong VW, Metz LM, Geurts JJ. Multi-scale MRI spectrum detects differences in myelin integrity between MS lesion types. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26754802 DOI: 10.1177/1352458515624771  1
2016 Popescu V, Schoonheim MM, Versteeg A, Chaturvedi N, Jonker M, Xavier de Menezes R, Gallindo Garre F, Uitdehaag BM, Barkhof F, Vrenken H. Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method. Plos One. 11: e0143942. PMID 26745873 DOI: 10.1371/Journal.Pone.0143942  1
2016 Coles A, Arnold D, Barkhof F, Filippi M, Hartung H, Havrdova E, Selmaj K, Margolin D, Thangavelu K, Schippling S, Investigators CI. Alemtuzumab Persistently Slows Brain Volume Loss In Rrms Journal of Neurology, Neurosurgery, and Psychiatry. 87. DOI: 10.1136/Jnnp-2016-315106.125  1
2016 Prins ND, Bergeron D, Groot C, Loenhoud ACv, Laforce R, Berckel BNMv, Barkhof F, Flier WMvd, Scheltens P, Ossenkoppele R. Impact Of Co-Morbid Amyloid Pathology On Clinical Phenotype Of Patients With Vascular Cognitive Disorders Alzheimers & Dementia. 12: 472. DOI: 10.1016/J.Jalz.2016.06.926  1
2016 Flier WMvd, Pölönen H, Koikkalainen J, Tolonen A, Meester HFR, Tijms BM, Lemstra AW, Barkhof F, Koene T, Teunissen CE, Rueckert D, Remes A, Waldemar G, Hasselbalch SG, Mecocci P, et al. Cost-Efficient Differential Diagnostics Of Neurodegenerative Diseases Using A Stratified Approach Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.922  1
2016 Maurik ISv, Bouwman FH, Teunissen CE, Scheltens P, Barkhof F, Wattjes M, Berkhof J, Flier WMvd. Personalized Risk Estimates For Mci Patients: Taking Biomarkers Into The Clinic Alzheimers & Dementia. 12: 393. DOI: 10.1016/J.Jalz.2016.06.742  1
2016 Lötjönen J, Tolonen A, Meester HFR, Bruun M, Koikkalainen J, Barkhof F, Tijms BM, Lemstra AW, Koene T, Teunissen CE, Tong T, Guerrero R, Schuh A, Ledig C, Baroni M, et al. Towards Data-Driven Medicine In Differential Diagnostics Of Neurodegenerative Diseases Alzheimers & Dementia. 12: 355. DOI: 10.1016/J.Jalz.2016.06.657  1
2016 Tijms BM, Kate Mt, Gouw AA, Teunissen CE, Barkhof F, Scheltens P, Flier WMvd. Grey Matter Connectivity Is Associated With Time To Clinical Progression In Mild Cognitive Impairment, Independent Of Amyloid Status Alzheimers & Dementia. 12: 303. DOI: 10.1016/J.Jalz.2016.06.549  1
2016 Verfaillie SCJ, Slot RER, Tijms BM, Bouwman FH, Benedictus M, Overbeek J, Koene T, Vrenken H, Scheltens P, Barkhof F, Flier WMvd. Thinner Cortical Thickness In Patients With Subjective Cognitive Decline Is Related To Poor Memory Performance And Faster Decline Of Executive Function Alzheimers & Dementia. 12: 774. DOI: 10.1016/J.Jalz.2016.06.184  1
2016 Kate Mt, Visser PJ, Flier WMvd, Scheltens P, Barkhof F, Tijms BM. Atrophy Patterns Predicting Cognitive Decline In Non-Demented Subjects Are Independent Of Amyloid Pathology Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.177  1
2016 Leijenaar JF, Maurik ISv, Kuijer J, Flier WMvd, Scheltens P, Barkhof F, Prins ND. Cerebral Blood Flow Measured With Phase-Contrast Mri In Ad, Mci And Controls Alzheimers & Dementia. 12: 706. DOI: 10.1016/J.Jalz.2016.06.1389  1
2016 Rojkova K, Cavedo E, Schotten MTd, Lista S, Brueggen K, Bokde ALW, Dubois B, Barkhof F, Pouwels PJW, Teipel SJ, Hampel H. Reduced White Matter Integrity Of The Rostral Limbic System Pathways In Healthy Elderly Apoe E4 Allele Carriers Alzheimers & Dementia. 12: 721. DOI: 10.1016/J.Jalz.2016.06.1377  1
2016 Bron EE, Young AL, Oxtoby NP, Smits M, Swieten JCv, Wink AM, Flier WMvd, Barkhof F, Golay X, Niessen WJ, Klein S, Alexander DC. Cross-Sectional Modeling Of Regional Perfusion And Gray Matter Volume In Alzheimer'S Disease Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.136  1
2016 Tijms BM, Kate Mt, Verfaillie SCJ, Gouw AA, Teunissen CE, Barkhof F, Scheltens P, Flier WMvd. Grey Matter Connectivity Is Associated With Clinical Progression In Non-Demented, Amyloid Positive Patients Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.072  1
2016 Braber Ad, Konijnenberg E, Kate Mt, Tijms BM, Barkhof F, Boomsma DI, Scheltens P, Visser PJ. Correlation of cortical thickness in cognitively healthy elderly monozygotic twin pairs Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.069  1
2015 Liu Y, Dai Z, Duan Y, Huang J, Ren Z, Liu Z, Dong H, Shu N, Vrenken H, Wattjes MP, Barkhof F, He Y, Li K. Whole brain functional connectivity in clinically isolated syndrome without conventional brain MRI lesions. European Radiology. PMID 26714968 DOI: 10.1007/S00330-015-4147-8  1
2015 van Duinkerken E, Ijzerman RG, Klein M, Moll AC, Snoek FJ, Scheltens P, Pouwels PJ, Barkhof F, Diamant M, Tijms BM. Disrupted subject-specific gray matter network properties and cognitive dysfunction in type 1 diabetes patients with and without proliferative retinopathy. Human Brain Mapping. PMID 26700243 DOI: 10.1002/Hbm.23096  1
2015 Jokinen H, Gonçalves N, Vigário R, Lipsanen J, Fazekas F, Schmidt R, Barkhof F, Madureira S, Verdelho A, Inzitari D, Pantoni L, Erkinjuntti T. Early-Stage White Matter Lesions Detected by Multispectral MRI Segmentation Predict Progressive Cognitive Decline. Frontiers in Neuroscience. 9: 455. PMID 26696814 DOI: 10.3389/Fnins.2015.00455  1
2015 Jonkman LE, Fleysher L, Steenwijk MD, Koeleman JA, de Snoo TP, Barkhof F, Inglese M, Geurts JJ. Ultra-high field MTR and qR2* differentiates subpial cortical lesions from normal-appearing gray matter in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26672996 DOI: 10.1177/1352458515620499  1
2015 Hafkemeijer A, Möller C, Dopper EG, Jiskoot LC, van den Berg-Huysmans AA, van Swieten JC, van der Flier WM, Vrenken H, Pijnenburg YA, Barkhof F, Scheltens P, van der Grond J, Rombouts SA. Differences in structural covariance brain networks between behavioral variant frontotemporal dementia and Alzheimer's disease. Human Brain Mapping. PMID 26660857 DOI: 10.1002/Hbm.23081  1
2015 Liu Y, Lukas C, Steenwijk M, Daams M, Versteeg A, Duan Y, Li K, Weiler F, Hahn HK, Wattjes MP, Barkhof F, Vrenken H. Multicenter Validation of Mean Upper Cervical Cord Area Measurements from Head 3D T1-Weighted MR Imaging in Patients with Multiple Sclerosis. Ajnr. American Journal of Neuroradiology. PMID 26659338 DOI: 10.3174/Ajnr.A4635  1
2015 Möller C, Pijnenburg YA, van der Flier WM, Versteeg A, Tijms B, de Munck JC, Hafkemeijer A, Rombouts SA, van der Grond J, van Swieten J, Dopper E, Scheltens P, Barkhof F, Vrenken H, Wink AM. Alzheimer Disease and Behavioral Variant Frontotemporal Dementia: Automatic Classification Based on Cortical Atrophy for Single-Subject Diagnosis. Radiology. 150220. PMID 26653846 DOI: 10.1148/Radiol.2015150220  1
2015 Steenwijk MD, Geurts JJ, Daams M, Tijms BM, Wink AM, Balk LJ, Tewarie PK, Uitdehaag BM, Barkhof F, Vrenken H, Pouwels PJ. Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant. Brain : a Journal of Neurology. PMID 26637488 DOI: 10.1093/Brain/Awv337  1
2015 Möller C, Hafkemeijer A, Pijnenburg YA, Rombouts SA, van der Grond J, Dopper E, van Swieten J, Versteeg A, Pouwels PJ, Barkhof F, Scheltens P, Vrenken H, van der Flier WM. Joint assessment of white matter integrity, cortical and subcortical atrophy to distinguish AD from behavioral variant FTD: A two-center study. Neuroimage. Clinical. 9: 418-29. PMID 26594624 DOI: 10.1016/J.Nicl.2015.08.022  1
2015 Rhodius-Meester HF, Koikkalainen J, Mattila J, Teunissen CE, Barkhof F, Lemstra AW, Scheltens P, Lötjönen J, van der Flier WM. Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers. Journal of Alzheimer's Disease : Jad. PMID 26577521 DOI: 10.3233/Jad-150548  1
2015 Steenwijk MD, Vrenken H, Jonkman LE, Daams M, Geurts JJ, Barkhof F, Pouwels PJ. High-resolution T1-relaxation time mapping displays subtle, clinically relevant, gray matter damage in long-standing multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26564997 DOI: 10.1177/1352458515615953  1
2015 Wattjes MP, Wijburg MT, Vennegoor A, Witte BI, Roosendaal SD, Sanchez E, Liu Y, Martins Jarnalo CO, Richert ND, Uitdehaag BM, Barkhof F, Killestein J. Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26564995 DOI: 10.1177/1352458515615225  1
2015 Tijms BM, Kate MT, Wink AM, Visser PJ, Ecay M, Clerigue M, Estanga A, Garcia Sebastian M, Izagirre A, Villanua J, Martinez Lage P, van der Flier WM, Scheltens P, Sanz Arigita E, Barkhof F. Gray matter network disruptions and amyloid beta in cognitively normal adults. Neurobiology of Aging. PMID 26559882 DOI: 10.1016/J.Neurobiolaging.2015.10.015  1
2015 Enzinger C, Barkhof F, Ciccarelli O, Filippi M, Kappos L, Rocca MA, Ropele S, Rovira À, Schneider T, de Stefano N, Vrenken H, Wheeler-Kingshott C, Wuerfel J, Fazekas F. Nonconventional MRI and microstructural cerebral changes in multiple sclerosis. Nature Reviews. Neurology. PMID 26526531 DOI: 10.1038/Nrneurol.2015.194  1
2015 Gardeniers M, Wattjes MP, Meulen EF, Barkhof F, Bakker J. [Diagnostic imaging in dementia: use of imaging modalities in Dutch memory clinics]. Tijdschrift Voor Gerontologie En Geriatrie. PMID 26525706 DOI: 10.1007/S12439-015-0154-0  1
2015 Krudop WA, Dols A, Kerssens CJ, Prins ND, Möller C, Schouws S, Barkhof F, van Berckel BN, Teunissen CE, van der Flier WM, Scheltens P, Sikkes SA, Stek ML, Pijnenburg YA. Impact of Imaging and Cerebrospinal Fluid Biomarkers on Behavioral Variant Frontotemporal Dementia Diagnosis within a Late-Onset Frontal Lobe Syndrome Cohort. Dementia and Geriatric Cognitive Disorders. 41: 16-26. PMID 26473985 DOI: 10.1159/000441023  1
2015 Cohen J, Belova A, Selmaj K, Wolf C, Sormani MP, Oberyé J, van den Tweel E, Mulder R, Koper N, Voortman G, Barkhof F. Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis: A Randomized Clinical Trial. Jama Neurology. 1-9. PMID 26458034 DOI: 10.1001/Jamaneurol.2015.2154  1
2015 Munger KL, Fitzgerald KC, Freedman MS, Hartung HP, Miller DH, Montalbán X, Edan G, Barkhof F, Suarez G, Radue EW, Sandbrink R, Kappos L, Pohl C, Ascherio A. No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT. Neurology. 85: 1694-701. PMID 26453645 DOI: 10.1212/Wnl.0000000000002099  1
2015 Hafkemeijer A, Möller C, Dopper EG, Jiskoot LC, Schouten TM, van Swieten JC, van der Flier WM, Vrenken H, Pijnenburg YA, Barkhof F, Scheltens P, van der Grond J, Rombouts SA. Resting state functional connectivity differences between behavioral variant frontotemporal dementia and Alzheimer's disease. Frontiers in Human Neuroscience. 9: 474. PMID 26441584 DOI: 10.3389/Fnhum.2015.00474  1
2015 Tillema JM, Hulst HE, Rocca MA, Vrenken H, Steenwijk MD, Damjanovic D, Enzinger C, Ropele S, Tedeschi G, Gallo A, Ciccarelli O, Rovira A, Montalban X, de Stefano N, Stromillo ML, ... ... Barkhof F, et al. Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26432859 DOI: 10.1177/1352458515607650  1
2015 Liu Y, Fu Y, Schoonheim MM, Zhang N, Fan M, Su L, Shen Y, Yan Y, Yang L, Wang Q, Zhang N, Yu C, Barkhof F, Shi FD. Structural MRI substrates of cognitive impairment in neuromyelitis optica. Neurology. PMID 26423432 DOI: 10.1212/Wnl.0000000000002067  1
2015 Adriaanse SM, Wink AM, Tijms BM, Ossenkoppele R, Verfaillie S, Lammertsma AA, Boellaard R, Scheltens P, van Berckel BN, Barkhof F. The association of glucose metabolism and eigenvector centrality in Alzheimer's disease. Brain Connectivity. PMID 26414628 DOI: 10.1089/Brain.2014.0320  1
2015 Duits FH, Hernandez-Guillamon M, Montaner J, Goos JD, Montañola A, Wattjes MP, Barkhof F, Scheltens P, Teunissen CE, van der Flier WM. Matrix Metalloproteinases in Alzheimer's Disease and Concurrent Cerebral Microbleeds. Journal of Alzheimer's Disease : Jad. PMID 26402072 DOI: 10.3233/Jad-143186  1
2015 Brueggen K, Dyrba M, Barkhof F, Hausner L, Filippi M, Nestor PJ, Hauenstein K, Klöppel S, Grothe MJ, Kasper E, Teipel SJ. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study. Journal of Alzheimer's Disease : Jad. 48: 197-204. PMID 26401940 DOI: 10.1016/J.Jalz.2015.06.127  1
2015 Tillema JM, Derks MG, Pouwels PJ, de Graaf P, van Rappard DF, Barkhof F, Steenweg ME, van der Knaap MS, Wolf NI. Volumetric MRI data correlate to disease severity in metachromatic leukodystrophy. Annals of Clinical and Translational Neurology. 2: 932-40. PMID 26401514 DOI: 10.1002/Acn3.232  1
2015 Ten Kulve JS, Veltman DJ, van Bloemendaal L, Barkhof F, Deacon CF, Holst JJ, Konrad RJ, Sloan JH, Drent ML, Diamant M, IJzerman RG. Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes. Diabetologia. PMID 26385462 DOI: 10.1007/S00125-015-3754-X  1
2015 Wattjes MP, Wijburg MT, Vennegoor A, Witte BI, de Vos M, Richert ND, Uitdehaag BM, Barkhof F, Killestein J. MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 26369555 DOI: 10.1136/Jnnp-2015-311411  1
2015 Wattjes MP, Rovira À, Miller D, Yousry TA, Sormani MP, de Stefano N, Tintoré M, Auger C, Tur C, Filippi M, Rocca MA, Fazekas F, Kappos L, Polman C, Barkhof F, et al. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-establishing disease prognosis and monitoring patients. Nature Reviews. Neurology. PMID 26369511 DOI: 10.1038/Nrneurol.2015.157  1
2015 van Bloemendaal L, Veltman DJ, Ten Kulve JS, Drent ML, Barkhof F, Diamant M, IJzerman RG. Emotional eating is associated with increased brain responses to food-cues and reduced sensitivity to GLP-1 receptor activation. Obesity (Silver Spring, Md.). PMID 26331843 DOI: 10.1002/Oby.21200  1
2015 Ten Kulve JS, Veltman DJ, van Bloemendaal L, Barkhof F, Drent ML, Diamant M, IJzerman RG. Liraglutide Reduces CNS Activation in Response to Visual Food Cues Only After Short-term Treatment in Patients With Type 2 Diabetes. Diabetes Care. PMID 26283736 DOI: 10.2337/Dc15-0772  1
2015 Ossenkoppele R, Cohn-Sheehy BI, La Joie R, Vogel JW, Möller C, Lehmann M, van Berckel BN, Seeley WW, Pijnenburg YA, Gorno-Tempini ML, Kramer JH, Barkhof F, Rosen HJ, van der Flier WM, Jagust WJ, et al. Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease. Human Brain Mapping. PMID 26260856 DOI: 10.1002/Hbm.22927  1
2015 Daams M, Steenwijk MD, Schoonheim MM, Wattjes MP, Balk LJ, Tewarie PK, Killestein J, Uitdehaag BM, Geurts JJ, Barkhof F. Multi-parametric structural magnetic resonance imaging in relation to cognitive dysfunction in long-standing multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26209593 DOI: 10.1177/1352458515596598  1
2015 Oudega ML, Dols A, Adelerhof I, Rozing M, Wattjes MP, Comijs HC, Barkhof F, Eikelenboom P, Stek ML, van Exel E. Contribution of white matter hyperintensities, medial temporal lobe atrophy and cortical atrophy on outcome, seven to twelve years after ECT in severely depressed geriatric patients. Journal of Affective Disorders. 185: 144-8. PMID 26186529 DOI: 10.1016/J.Jad.2015.07.011  1
2015 Benedictus MR, van Harten AC, Leeuwis AE, Koene T, Scheltens P, Barkhof F, Prins ND, van der Flier WM. White Matter Hyperintensities Relate to Clinical Progression in Subjective Cognitive Decline. Stroke; a Journal of Cerebral Circulation. 46: 2661-4. PMID 26173729 DOI: 10.1161/Strokeaha.115.009475  1
2015 Jovicich J, Minati L, Marizzoni M, Marchitelli R, Sala-Llonch R, Bartrés-Faz D, Arnold J, Benninghoff J, Fiedler U, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, et al. Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study. Neuroimage. PMID 26163799 DOI: 10.1016/J.Neuroimage.2015.07.010  1
2015 Rovira À, Wattjes MP, Tintoré M, Tur C, Yousry TA, Sormani MP, De Stefano N, Filippi M, Auger C, Rocca MA, Barkhof F, Fazekas F, Kappos L, Polman C, Miller D, et al. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process. Nature Reviews. Neurology. 11: 471-82. PMID 26149978 DOI: 10.1038/Nrneurol.2015.106  1
2015 Ossenkoppele R, Pijnenburg YA, Perry DC, Cohn-Sheehy BI, Scheltens NM, Vogel JW, Kramer JH, van der Vlies AE, Joie RL, Rosen HJ, van der Flier WM, Grinberg LT, Rozemuller AJ, Huang EJ, van Berckel BN, ... ... Barkhof F, et al. The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features. Brain : a Journal of Neurology. 138: 2732-49. PMID 26141491 DOI: 10.1093/Brain/Awv191  1
2015 Daams M, Steenwijk MD, Wattjes MP, Geurts JJ, Uitdehaag BM, Tewarie PK, Balk LJ, Pouwels PJ, Killestein J, Barkhof F. Unraveling the neuroimaging predictors for motor dysfunction in long-standing multiple sclerosis. Neurology. 85: 248-55. PMID 26115736 DOI: 10.1212/Wnl.0000000000001756  1
2015 Geytenbeek JJ, Oostrom KJ, Harlaar L, Becher JG, Knol DL, Barkhof F, Pinto PS, Vermeulen RJ. Language comprehension in nonspeaking children with severe cerebral palsy: Neuroanatomical substrate? European Journal of Paediatric Neurology : Ejpn : Official Journal of the European Paediatric Neurology Society. 19: 510-20. PMID 26112263 DOI: 10.1016/J.Ejpn.2015.06.001  1
2015 Cohen JA, Khatri B, Barkhof F, Comi G, Hartung HP, Montalban X, Pelletier J, Stites T, Ritter S, von Rosenstiel P, Tomic D, Kappos L. Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 26111826 DOI: 10.1136/Jnnp-2015-310597  1
2015 Jain S, Sima DM, Ribbens A, Cambron M, Maertens A, Van Hecke W, De Mey J, Barkhof F, Steenwijk MD, Daams M, Maes F, Van Huffel S, Vrenken H, Smeets D. Automatic segmentation and volumetry of multiple sclerosis brain lesions from MR images. Neuroimage. Clinical. 8: 367-75. PMID 26106562 DOI: 10.1016/J.Nicl.2015.05.003  1
2015 van Bloemendaal L, Veltman DJ, Ten Kulve JS, Groot PF, Ruhé HG, Barkhof F, Sloan JH, Diamant M, Ijzerman RG. Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans. Diabetes, Obesity & Metabolism. 17: 878-86. PMID 26094857 DOI: 10.1111/Dom.12506  1
Show low-probability matches.